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Running Title: Nmu regulates zebrafish arousal 
 
Summary 
Neuromodulation of arousal states ensures that an animal appropriately responds to its 
environment and engages in behaviors necessary for survival. However, the molecular and 
circuit properties underlying neuromodulation of arousal states such as sleep and wakefulness 
remain unclear. To tackle this challenge in a systematic and unbiased manner, we performed a 
genetic overexpression screen to identify genes that affect larval zebrafish arousal. We found that 
the neuropeptide neuromedin U (Nmu) promotes hyperactivity and inhibits sleep in zebrafish 
larvae, whereas nmu mutant animals are hypoactive. We show that Nmu-induced arousal 
requires Nmu receptor 2 and signaling via corticotrophin-releasing hormone (Crh) receptor 1. In 
contrast to previously proposed models, we find that Nmu does not promote arousal via the 
hypothalamic-pituitary-adrenal axis, but rather likely acts via brainstem crh-expressing neurons. 
These results reveal an unexpected functional and anatomical interface between the Nmu system 
and brainstem arousal systems that represents a novel wake-promoting pathway. 
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Introduction 
A major challenge in neuroscience is to understand the molecular and neural circuitry that 
regulates arousal states such as sleep and wakefulness, which are fundamental to animal behavior 
and function. While decades of research have uncovered some of the molecular, anatomical and 
functional properties of the brain systems that regulate sleep and wakefulness, the overwhelming 
evidence indicates that there are many parallel systems regulating vertebrate arousal states, with 
many players remaining to be discovered. 
 
Large-scale screening offers the potential to discover novel mechanisms of arousal, including 
sleep/wake regulation, but the challenge of performing behavioral genetic screens using 
mammalian model organisms is daunting. While genetic screens for sleep/wake regulators have 
been successful in Drosophila (Cirelli et al., 2005; Koh et al., 2008; Pfeiffenberger and Allada, 
2012; Rogulja and Young, 2012; Stavropoulos and Young, 2011), flies lack mammalian sleep 
regulators like orexin/hypocretin (Hcrt), and some of the genes identified in fly screens lack clear 
vertebrate orthologs. In contrast to mammals, zebrafish (Danio rerio) are well suited for large-
scale screens. Indeed, two large-scale forward genetic screens for developmental and simple 
behavioral phenotypes stimulated the widespread adoption of zebrafish as a model system 
(Driever et al., 1996; Haffter et al., 1996). Though fruitful, traditional F2 screening approaches 
are associated with a high cost because they require the generation of large collections of mutant 
lines and considerable challenges in identifying the causative genetic lesions. F1 screens bypass 
this requirement and therefore offer the advantage of efficiency in time, expense, and labor. 
 
Another obstacle to understanding the regulation of sleep/wake states is the challenge of 
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functionally and anatomically dissecting complex mammalian arousal systems. One source of 
complexity is the presence of multiple neurochemical and anatomical systems with overlapping 
or interlinked functions in arousal. For example, some constitutive loss-of function models that 
disrupt well-studied arousal pathways, such as those mediated by adenosine, histamine and 
noradrenaline, yield only subtle or no sleep phenotypes in rodents (Huang et al., 2007; Hunsley 
and Palmiter, 2003; Thakkar, 2011). In contrast, acute pharmacological manipulations of these 
pathways have profound effects on sleep/wake behaviors (Huang et al., 2007; Hunsley and 
Palmiter, 2003; Thakkar, 2011), suggesting that developmental compensatory mechanisms may 
mask phenotypes in constitutive loss-of-function models. Thus, in general, the redundancy of 
arousal pathways makes inducible, gain-of-function manipulations more suitable for identifying 
mechanisms involved in arousal. 
 
To complement the existing repertoire of screening and circuit characterization approaches, we 
developed a screening and follow-up approach that leverages several features of the zebrafish 
system. We designed and implemented an injection-based, inducible gene overexpression 
screening methodology to identify genes that regulate vertebrate sleep/wake behavior. This 
approach offers the power of inducible, gain-of-function approaches combined with the 
efficiency of F1 screens. To our knowledge, this is the largest-scale genetic screen for 
sleep/wake regulators in a vertebrate animal. In this screen, we identified neuromedin U (Nmu) 
as a neuropeptide regulator of zebrafish sleep/wake behavior. Using a combination of 
pharmacology and genetics, we also provide a mechanistic basis for Nmu-mediated arousal in 
zebrafish that shares some features of Nmu signaling in mammals. In mammals, Nmu has been 
shown to promote locomotor activity, which was hypothesized to act via the hypothalamic-
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pituitary-adrenal (HPA) axis (Hanada et al., 2001). In contrast to this model, we find that Nmu 
overexpression induced phenotypes do not require HPA axis signaling. Instead, we uncovered an 
unexpected and previously unexamined link between the Nmu system and brainstem arousal 
circuits. Our data implicate a new circuit in the regulation of vertebrate arousal and, more 
broadly, validates our genetic screen design. 
 
Results 
A zebrafish inducible genetic overexpression screen for sleep regulators 
Our genetic screen features four design components (Figures 1A-1C). First, we leveraged the 
hORFeome 3.1 collection (http://horfdb.dfci.harvard.edu), a publicly available set of cloned 
human open reading frames (ORFs, i.e. potential protein-coding regions of DNA), to conduct the 
screen on a large scale.  We used human genes because a resource of zebrafish ORFs was not 
available, and we reasoned that most human peptides would be functional in zebrafish due to 
high sequence conservation. We cross-referenced the hORFeome 3.1 collection with the 
LOCATE database (http://locate.imb.uq.edu.au), which annotates 4418 human ORFs that are 
known or predicted to encode secreted proteins (Secretome). The hORFeome 3.1 contains 1632 
of these ORFs. Thus, we cloned over one-third (1632 ORFs in hORFeome 3.1 / 4418 ORFs in 
the human Secretome = 37%) of the human Secretome for testing in zebrafish. We focused on 
secreted peptides because several known sleep regulators are secreted neuropeptides and because 
secreted peptides act non-cell autonomously, a technical advantage in that transgenes do not need 
to be overexpressed in all cells for secreted peptides to reach their targets. Second, we used an 
inducible overexpression transgene vector (hs:Sec, or Heat-Shock Secretome Gene) to avoid 
effects on development. Overexpression of a given Secretome candidate gene was achieved by 
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incubating zebrafish larvae at 37oC for 1 hour (Figure 1C). Third, we used a transgene injection 
approach for the primary screen. By directly testing larvae injected with a hs:Sec transgene, we 
circumvented the considerable labor, cost, and time required to test stable transgenic lines. This 
approach is possible using the Tol2 transposase (Asakawa and Kawakami, 2009), which 
efficiently integrates injected plasmids into the genome of injected embryos (Figures 1B and 
1C). We performed a proof-of-principle experiment with a plasmid in which the heat shock 
promoter regulates expression of the zebrafish Hcrt ortholog (hs:Hcrt_Dr) (Figure 1D), which 
confirmed that our injection-based approach achieves the same inducible hyperactivity as the 
previously published Tg(hs:Hcrt_Dr) stable transgenic line (Prober et al., 2006). Fourth, we 
employed a high-throughput locomotor activity assay (Prober et al., 2006) to identify genes that, 
when overexpressed, produced a quantifiable sleep/wake phenotype. Satisfying the behavioral 
criteria that distinguish sleep from inactivity in animals (Allada and Siegel, 2008), zebrafish 
larvae exhibit a diurnal pattern of activity and rest (Cahill et al., 1998; Zhdanova et al., 2001), 
increased rest following rest deprivation (Zhdanova et al., 2001), and an increased arousal 
threshold following one or more minutes of rest (Elbaz et al., 2012; Prober et al., 2006). Thus, 
one or more minutes of rest can be considered a sleep-like state in zebrafish larvae. Several 
groups have also demonstrated anatomical, genetic and pharmacological conservation of sleep 
between zebrafish and mammals, establishing zebrafish as a simple vertebrate model for sleep 
research (reviewed in Chiu and Prober, 2013; Zhdanova, 2011). 
 
In the primary screen, we performed 1432 experiments that tested 1286 unique ORFs covering 
1126 unique genes (Table S1). We therefore screened 29% (1286/4418) of the human 
Secretome, which is the largest screen to date for genes that affect vertebrate sleep/wake 
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patterns. For each ORF, we tested 32 injected embryos in the sleep/wake assay along with 16 
matched controls that were injected with either hs:EGFP or an empty hs vector. To assess the 
effects of each ORF on behavior, we divided each behavioral trace into pre- and post-heat shock 
epochs for each day and night (Figure 1D) and calculated alterations in sleep amount and 
structure (e.g. number and length of sleep bouts, sleep latency at night), as well as changes in 
activity levels (Figure S1 and Table S2). One such measure is the Activity Index, an assessment 
of the change in activity due to overexpression of an ORF normalized to the set of controls and 
internally controlled to the pre-HS epoch (Figure 1D). The collection of Activity Indices is 
normally distributed (Figure 1E) and identifies ORFs that up- or down-regulate activity when 
overexpressed. We calculated similar measures for effects on several other parameters, including 
total sleep, sleep bout number and length, sleep latency, and day activity levels (Figures S1A-
S1F). Based on these initial assessments of the primary screen, we selected 60 ORFs to confirm 
in stable transgenic lines (see Supplemental Experimental Procedures): 31/60 (52%) were chosen 
from the top ranks of the Activity Index (e.g. those that most strongly decreased or increased 
activity; (Figure 1E), 13/60 (22%) were based on the Night Sleep Index (Figure S1B), and the 
remaining 16/60 (26%) were based on strong single measure effects, for example alterations in 
sleep structure like the number or length of sleep bouts, or strong day vs. night effects (Figure 
S1C-S1F). These measures are capable of identifying regulators of zebrafish sleep and activity, 
including hypocretin (Hcrt), a previously described promoter of activity (Figures 1D and 1E, Z-
score Activity Index = 2.1) (Prober et al., 2006), and prepronociceptin (Pnoc), a previously 
described repressor of activity (Figures 1F and S1F, Z-score Activity Index= -1.3; Z-Score Post-
HS Day Activity, -2.0) (Woods et al., 2014). Table S2 provides summary statistics for these 
sleep/wake parameters. Of the 60 peptides overexpressed in stable transgenic lines, 10 (17%) 
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gave reproducible phenotypes as expected from the primary screen and another two lines gave 
unexpected phenotypes (Table S3). These will be described in more detail elsewhere. 
 
Identification of neuromedin U (Nmu) as a neuropeptidergic regulator of sleep/wake 
behavior in zebrafish 
One strong enhancer of post-HS locomotor activity was Nmu (Figures 1E and 1G; activity index 
Z-score=2.0). Overexpression of human Nmu (hs:Nmu_Hs) significantly increased locomotor 
activity compared to pre-heat shock and to EGFP overexpressing controls (Figure 1G). 
Overexpression of human Nmu using a stable line generated from the same transgene also 
significantly increased locomotor activity, although the temporal dynamics of this phenotype was 
different from that observed in the screen, likely due to leaky nmu expression by the heat shock 
promoter in this stable line (Figure 1H). 
 
To determine whether the mammalian Nmu system is conserved in zebrafish, we first cloned the 
zebrafish ortholog. The zebrafish genome contains a single nmu ortholog that encodes a 
predicted 25 amino acid-length mature peptide that is 56% identical to human mature peptide 
Nmu-25 (Figures 2A, S2A and S2B). Based on structure-function studies of vertebrate Nmu, the 
C-terminal heptapeptide sequence is known to contain the critical region for biological activity 
(Hashimoto et al., 1991; Sakura et al., 1991). There is significant conservation of this region, as 
zebrafish Nmu retains 6 of 7 mammalian Nmu C-terminal amino acids, including a 
phenylalanine (F) residue that is important for activity (Kurosawa et al., 1996) and an arginine 
(R) residue that is indispensable for receptor binding and activation (Sakura et al., 2000) (Figures 
2A and S2B). 
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Using in situ hybridization (ISH), we found that zebrafish nmu is expressed in discrete nuclei 
within the central nervous system of embryonic and larval zebrafish. At 24 hours post-
fertilization (hpf), a single bilateral cell cluster occupies the caudal brainstem and an additional 
bilateral row of neurons is present in the spinal cord (Figure 2B). These cell populations persist 
at 48 hpf, and additionally a bilateral hypothalamic population appears at this stage (Figures 2C 
and 2D). At 120 hpf, additional cells differentiate in the hypothalamus (Figures 2E and 2F, 
Movie S1). This pattern of expression accords with nmu expression in the adult mammalian 
central nervous system in hypothalamus, brainstem, and spinal cord (Austin et al., 1994; Fujii et 
al., 2000; Graham et al., 2003; Howard et al., 2000; Ivanov et al., 2002; Nogueiras et al., 2006; 
Szekeres et al., 2000). We did not observe peripheral expression of nmu in the gastrointestinal or 
genitourinary tracts, or in the skin, as has been reported in mammals. 
 
Next we examined the functional role of zebrafish Nmu. Most studies of Nmu in mammals have 
focused on its role in regulating appetite, but several studies have also shown that Nmu can 
induce short-term increases in locomotor activity or grooming following acute, central 
administration of Nmu peptide (Howard et al., 2000; Nakazato et al., 2000; Novak et al., 2006, 
2007; Peier et al., 2009; Semjonous et al., 2009; Wren et al., 2002). Thus, we first asked whether 
overexpression of the zebrafish Nmu ortholog in zebrafish produces a similar increased 
locomotor activity phenotype. We found that heat shock-induced overexpression of the zebrafish 
Nmu ortholog using a stable transgenic line (Tg(hs:Nmu_Dr)) (Figure S3) recapitulated the 
increased locomotor activity phenotype induced by Tg(hs:Nmu_Hs) in zebrafish, causing a large 
increase in wake activity (i.e. amount of locomotor activity while awake; Figures 3A and 3A’). 
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Thus, overexpression of Nmu in zebrafish and central administration of Nmu peptide in rodents 
both promote locomotor activity. 
 
We further characterized the functional role of zebrafish Nmu by employing several additional 
assays of arousal. First, we characterized the effects of Nmu overexpression on spontaneous 
sleep/wake architecture. We found that sleep in Nmu overexpressing larvae is dramatically 
reduced during both day and night, and is almost completely abolished during the night 
following heat shock (Figures 3B and 3B’). Further analysis of the effects of Nmu 
overexpression on sleep structure at night revealed an increase in sleep latency (Figure 3C), a 
decrease in the frequency of sleep bouts (Figure 3D), a decrease in sleep bout length (Figure 3E) 
and a reciprocal increase in wake bout length (Figure 3F). Thus, the overall effect of Nmu 
overexpression on sleep/wake architecture is to cause hyperactivity, reduce total sleep time and 
disrupt the initiation and maintenance of sleep, resulting in a severe insomnia-like phenotype. 
 
Next, we asked whether Nmu-induced phenotypes require external circadian entrainment signals 
(zeitgebers) such as light. First we tested larvae that were entrained to 14:10 h light/dark (LD) 
conditions and then shifted into constant light (LL) or constant dark (DD) conditions. We 
observed that Nmu-induced phenotypes persist in LL or DD after LD entrainment (Figures S4A-
S4D’), indicating that external entraining light cues are not required for Nmu-induced 
phenotypes. We next tested larvae that had been raised without circadian entrainment (i.e. raised 
and tested in LL) and found that Nmu-induced phenotypes do not require rhythmic behavior 
(Figures S4E-S4F’). Together, these results suggest that neither external nor internal circadian 
cues are required for Nmu overexpression to modulate behavior. 
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We also asked whether Nmu can modulate arousal responses to acute external stimuli in addition 
to modulating spontaneous baseline activity. To test this hypothesis, we developed a simple 
behavioral paradigm in which larval zebrafish raised and tested in LD were exposed to brief, 1-
minute light pulses once every 2 hours throughout the dark phase (Figure 3G). We characterized 
the responses of wild-type (WT) larvae to the light pulse trials and found that, on average, larvae 
respond in a biphasic manner (Figure 3G). The first behavioral epoch, which we call the 
“stimulus-on” response, occurs within a few seconds of the stimulus onset. The second 
behavioral epoch, which we call the “post-stimulus” response, is initiated several minutes after 
stimulus offset. To quantify the behavioral responses during both of these epochs we measured 
the peak amplitude and total activity, as well as decay kinetics by fitting a single exponential 
curve to each response epoch (see Figures 3G, 3H and Supplemental Experimental Procedures 
for details). Using these measures, we found that the activity of WT larvae during the stimulus-
on epoch decays with a time constant of τ = 55.2±10.4 seconds (mean±SD, n=29, Figures 3G 
and 3K) whereas the post-stimulus activity persists much longer and decays with a time constant 
of τ = 10.4±1.9 minutes (mean±SD, n=29, Figures 3G and 3N). We found that Nmu 
overexpression modulates the stimulus-on response by shortening and reducing the total activity 
(Figures 3J-3L). Conversely, Nmu overexpressing larvae exhibit a larger, more prolonged 
response during the following post-stimulus epoch (Figures 3M-3O). Consistent with the effects 
of Nmu overexpression in our sleep/wake assay, we also observed an increase in baseline 
activity prior to stimulus onset in Nmu overexpressing larvae (Figure 3I). Taken together, our 
studies of zebrafish locomotor activity under various stimulus conditions show that Nmu 
modulates arousal by increasing spontaneous activity and secondary stimulus-evoked arousal 
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states, and paradoxically, Nmu modulates acute arousal responses by suppressing activity. 
 
nmu is required for normal arousal levels and Nmu overexpression-induced arousal 
requires nmur2 
To determine whether nmu is required for normal arousal levels and to test the functional 
requirement of each nmu receptor ortholog in mediating the Nmu overexpression phenotype, we 
generated zebrafish that contain a predicted null mutation in nmu and in each nmu receptor using 
zinc finger nuclease and TAL effector nuclease technologies (Figures S2C, S2D and S2F). The 
zebrafish genome contains 2 zebrafish Nmur1 orthologs, designated Nmur1a and Nmur1b, that 
are 52% and 49% identical to human Nmur1 (Figures S2C-S2E and S2H), and a single ortholog 
of Nmur2 that is 44% identical to human Nmur2 (Figures S2F-S2H). Using ISH, we observed 
that nmur2 is primarily expressed in discrete regions in the zebrafish brain, including cell 
clusters in the brainstem, hypothalamus and forebrain (Figures 2H and 2J-2L, Movie S2). We 
detected more restricted expression of nmur1a in a discrete cluster of rostro-ventral 
hypothalamic cells (Figures 2G and 2I), and we detected no nmur1b transcript in zebrafish up to 
120 hpf. Thus, like mammals, zebrafish nmur2 expression in the CNS is more widespread 
compared to nmur1 (reviewed by Brighton et al., 2004). 
 
Consistent with the Nmu overexpression phenotype, we found that nmu-/- larvae were less active 
during the day (Figure 4A and 4A’). nmu-/- adults were also less active (Figure 4C and 4C’), 
with the largest effect just prior to and following the onset of light in the morning (Figure 4D and 
4D’). Larvae lacking individual Nmu receptors exhibited largely normal sleep/wake behaviors 
(Figure S5A-SF). However, nmur2-/- adults exhibited a phenotype similar to that of nmu-/- 
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adults (Figure S5G and S5H), suggesting that either redundant mechanisms or maternal 
contribution may rescue the nmur2-/- phenotype in larvae but not adults. Furthermore, while the 
Nmu overexpression phenotype was unaffected in nmur1a and nmur1b mutants (Figure S5A-
S5D), it was abolished in nmur2 homozygous mutant larvae (Figure 5). These results suggest 
that Nmu and Nmur2 are required for normal arousal levels and that Nmu overexpression 
promotes arousal via Nmur2. 
 
In addition to its requirement for normal arousal levels, we also observed that nmu-/- adult fish 
were smaller and weighed less than their heterozygous mutant and WT siblings (Figure S6). 
Surprisingly, we observed a similar phenotype in nmur1a-/- adults, but not in nmur1b-/- or 
nmur2-/- adults (Figure S6). No size differences were observed in any of the mutants at the larval 
stage. These observations suggest that different Nmu receptors have different functional roles, 
with Nmur2 required for Nmu-dependent arousal and Nmur1a required for Nmu-dependent 
growth in adult fish. 
 
Nmu overexpression phenotype does not require the glucocorticoid receptor 
Next, we set out to delineate the downstream genetic and neural circuit mechanisms linking Nmu 
signaling via Nmur2 to a behavioral output. Given that Nmu induces hyperactivity in rodents and 
zebrafish, one candidate downstream pathway is the hypothalamic-pituitary-adrenal (HPA) axis, 
which mediates stress behavior. HPA axis signaling is initiated by corticotropin releasing 
hormone (crh)-expressing neurons of the paraventricular nucleus (PVN) of the hypothalamus 
and eventually activates adrenal cells that effect glucocorticoid (e.g. cortisol) signaling. Indeed, it 
was hypothesized that Nmu-induced hyperactivity is mediated by the HPA axis, based on the 
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observation that Nmu administration does not induce locomotor activity in crh mutant mice 
(Hanada et al., 2001). However, it was not determined which crh-expressing neurons were 
responsible for this effect. The hypothalamic-pituitary-interrenal (HPI) axis of zebrafish is 
homologous to the mammalian HPA axis, with cortisol/glucocorticoid receptor signaling 
conserved as the key effector of the HPA/HPI axis stress response (Alsop and Vijayan, 2008; De 
Marco et al., 2013; Wendelaar Bonga, 1997). To directly test the hypothesis that Nmu-induced 
hyperactivity is mediated by the HPA/HPI axis, we analyzed the effect of Nmu overexpression in 
zebrafish possessing a null mutation in the glucocorticoid receptor (gr) (Ziv et al., 2013), the 
classical target of the HPA/HPI cascade. Surprisingly, we found that the Nmu overexpression 
phenotype persisted in gr-/- larvae (Figure 6). This result suggests that Nmu-induced locomotor 
activity is not mediated by the HPA/HPI axis, but rather acts via an alternative Crh-dependent 
mechanism. 
 
Nmu-induced cfos activation in putative brainstem arousal systems expressing crh 
To generate new hypotheses of Nmu downstream signaling mechanisms, we used cfos 
expression as a read-out for neurons that are stimulated in response to Nmu signaling. We found 
that at one hour post-heat shock, Nmu overexpression induced cfos expression in several 
distributed cell populations, particularly in the forebrain and in discrete brainstem areas (Figure 
7A). Notably, some cfos-positive neurons mapped closely to nmur2-positive neurons in the 
brainstem (compare Figures 7A and 2L). We observed comparatively little cfos expression in 
brains of non-transgenic siblings that underwent identical heat shock treatment (Figure 7B), 
suggesting that the cfos labeling observed in Tg(hs:Nmu_Dr) larvae is specific to Nmu 
overexpression. 
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The anatomical location of one nucleus of cfos-positive neurons suggested that they might 
belong to brainstem populations that promote arousal in vertebrates. In mammals, extra-
hypothalamic crh expression has been observed in brainstem arousal nuclei, including the locus 
coeruleus and parabrachial nucleus (Morin et al., 1999). Thus, we hypothesized that Nmu 
overexpression might activate some of these brainstem crh-expressing neurons in zebrafish. To 
test this hypothesis, we performed double fluorescent ISH on brains from Tg(hs:Nmu_Dr) larvae 
and found that the brainstem cfos-positive neurons colocalized with crh (Figures 7C and 7D). 
Interestingly, colocalization of cfos and crh was specific to the brainstem, whereas cfos did not 
colocalize with crh-positive neurons in the zebrafish preoptic nucleus (Figure 7C), which is 
homologous to the mammalian hypothalamic PVN component of the HPA axis (Herget et al., 
2014). This result is consistent with the persistence of the Nmu overexpression phenotype in the 
gr mutant, and provides further evidence that the HPA/HPI axis is not a critical mediator of 
Nmu-induced arousal. Rather, our data is consistent with Nmu promoting arousal via brainstem 
arousal systems expressing crh. 
 
To address whether there is a direct signaling pathway between the Nmu system and Crh 
brainstem populations, we performed double fluorescent ISH on WT larvae to assess possible 
colocalization of nmur2 with the crh brainstem populations (Figure 7E). Expression of nmur2 
and crh in this region exhibit some overlap, and at least some nmur2-expressing cells in this 
region express cfos following Nmu overexpression (Figure 7F), but the majority of the nmur2 
expression does not colocalize with crh and instead resides in a closely neighboring population. 
These results suggest both direct and indirect pathways between the Nmu and Crh systems. 
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Finally, we examined the functional interaction between Nmu and Crh signaling. Based on data 
from the present study and previous mammalian studies (Hanada et al., 2001), we hypothesized 
that Crh mediates Nmu-induced arousal in larval zebrafish. We tested this hypothesis by 
blocking Crh signaling in the Nmu gain-of-function transgenic line. Indeed, we found that the 
Crhr1 antagonist NBI 27914, applied immediately following heat shock, blocked the Nmu 
overexpression-induced phenotype in a dose-dependent manner during the day following heat 
shock (Figures 7G and 7H). Notably, the antagonist significantly attenuated the Nmu 
overexpression-induced phenotype at concentrations that did not affect non-transgenic siblings 
(Figure 7H) suggesting that Nmu overexpressing larvae are more sensitive to the antagonist 
(p=2.9x10-6 genotype x drug interaction, 2 way ANOVA) and consistent with the hypothesized 
role of Crh signaling in Nmu-induced arousal. At 5 µM, the Crhr1 antagonist also reduced 
locomotor activity in non-transgenic sibling larvae (Figures 7G and 7H), consistent with a 
requirement for Crh signaling to maintain normal arousal levels. Taken together, our anatomical 
and functional data suggest that Nmu-induced arousal is mediated by Crh signaling in the 
brainstem. 
 
Discussion 
An overexpression screen to identify genes that regulate sleep 
By combining injection-based gene overexpression with high-throughput locomotor activity 
assays, we developed a novel and cost-effective approach to identify molecular regulators of 
zebrafish sleep/wake behaviors. Using a heat-shock inducible promoter to broadly overexpress 
secreted proteins overcomes several limitations of traditional screens. For example, broad 
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overexpression can produce more robust and reproducible phenotypes than tissue-restrictive 
approaches and haplo-insufficient mutagenesis, as well as chemical mutagenesis approaches that 
induce thousands of mutations in each animal. Inducible gene overexpression also increases the 
sensitivity of the screen because phenotypes are compared before and after gene overexpression 
in the same animals. Furthermore, our inducible approach circumvents developmental 
compensatory mechanisms, which may mask phenotypes, and allows for the analysis of genes 
with developmental functions.  
 
A significant limitation of the screen was a high false positive rate, with only 10 of the 60 hits 
from the primary screen producing the expected phenotype in stable transgenic lines. This high 
false positive rate is partly due to our relatively relaxed cutoff in the primary screen. However, 
had we used a more stringent threshold, we would have missed key genes such as Nmu and 
potentially biased the results for strong, non-physiological effectors. It is unclear if false 
positives were also due to poor reproducibility of the injection procedure, the number of larvae 
tested for each gene, the variable nature of sleep/wake behavioral phenotypes, or the use of 
human genes. 
 
The screen identified Nmu as a conserved regulator of locomotor activity in vertebrates. We 
further identified a role for Nmu and its receptor Nmur2 in regulating sleep/wake architecture in 
zebrafish. In contrast to a previous hypothesis that Nmu-induced locomotor activity is mediated 
by the HPA/HPI stress axis, our results suggest that brainstem Crh neurons mediate the function 
of Nmu in vertebrate sleep/wake regulation (Figure 8). The interaction between the Nmu system 
and brainstem Crh arousal systems represents a novel vertebrate arousal circuit. 
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Conserved molecular circuitry and motor function of Nmu 
We found that the Nmu peptide sequence and expression pattern in the brain are well-conserved 
from mammals to zebrafish. Furthermore, we found that Nmu overexpression promotes 
wakefulness and hyperarousal in zebrafish, consistent with the increased physical activity 
observed in mammals following acute administration of Nmu peptide (Nakazato et al., 2000; 
Novak et al., 2006, 2007; Peier et al., 2009; Semjonous et al., 2009; Wren et al., 2002). We also 
observed arousal defects in nmu mutant zebrafish larvae and adults. Larval zebrafish nmu 
mutants are less active during the day, suggesting that nmu is required for normal daytime 
arousal levels. The adult zebrafish nmu mutant phenotype is most prominent just prior to and 
following the onset of light in the morning, suggesting that Nmu is particularly important in 
promoting the transition from nighttime sleep to daytime wakefulness. In rodents, the role of 
endogenous nmu in sleep and arousal is unclear, as one study observed locomotor defects in nmu 
mutant mice (Hanada et al., 2004), whereas a recent study using the same strain did not (Lee et 
al., 2015). 
 
The two mammalian Nmu receptors are also conserved in zebrafish, which have two orthologs of 
mammalian nmur1 (nmur1a and nmur1b), and one ortholog of mammalian nmur2. Similar to 
mammals (Gartlon et al., 2004), zebrafish nmur2 is enriched in widespread yet specific regions 
of the brain, whereas nmur1a is sparsely expressed in the brain and nmur1b expression is 
undetected up to 120 hpf. The effects of Nmu peptide administration on physical activity are 
absent in nmur2 knockout mice, indicating that Nmur2 is required to mediate Nmu-induced 
locomotor activity in rodents (Peier et al., 2009; Zeng et al., 2006). Similarly, we find that 
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locomotor phenotypes induced by Nmu overexpression are abolished in nmur2-/- zebrafish, but 
persist in nmur1a-/- and nmur1b-/- zebrafish. Thus, the role of Nmur2 as the primary mediator of 
Nmu-induced locomotor activity is conserved from mammals to zebrafish. We furthermore 
extend the behavioral roles for Nmur2 to regulating arousal and insomnia phenotypes induced by 
Nmu overexpression. 
 
Intriguingly, nmur2 knock-out mice were reported to not exhibit locomotor activity phenotypes, 
although behavior was only monitored for short time intervals during the day (Peier et al., 2009; 
Zeng et al., 2006). Although we observed little or no locomotor activity phenotypes in nmur2 
mutant zebrafish larvae, we did observe reduced locomotor activity in adult zebrafish, with the 
strongest effects observed in the morning after lights on, consistent with the zebrafish nmu 
mutant adult phenotype. Therefore, the reported differences in nmur2-/- locomotor phenotypes 
between rodents and zebrafish may be due to the time of day when observations are made. 
 
In addition to effects on behavior, we observed that both the nmu and nmur1a mutants, but not 
the nmur1b or nmur2 mutants, are significantly smaller as adults. These observations suggest 
that Nmur1a and Nmur2 mediate distinct aspects of Nmu function. The small size of adult 
zebrafish nmu and nmur1a mutants is surprising given that the mouse nmu mutant is obese 
(Hanada et al., 2004). However, the mouse nmur1 mutant does not exhibit growth abnormalities 
and the mouse nmur2 mutant exhibits a growth defect that correlates with decreased feeding 
(Peier et al., 2009). It may be that differences in feeding schedules contribute to differences in 
Nmu mutant phenotypes; zebrafish are given a restricted feeding regimen whereas mice were fed 
ad libitum.  
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Role of Nmu in modulating spontaneous vs. stimulus-evoked arousal 
Our analyses of sleep/wake architecture refine the previously established role of Nmu in 
regulating locomotor activity in vertebrates. Nmu overexpression consolidates waking bouts into 
periods of prolonged hyperactivity and shortens and reduces initiations to sleep, similar to 
insomnia. The effect of Nmu on sleep/wake architecture has not been extensively examined in 
other species, but our results are consistent with the short-term effect of acute 
intracerebroventricular injection of Nmu in rats, namely prolonged wakefulness and disrupted 
sleep (Ahnaou and Drinkenburg, 2011). 
 
We also examined effects of Nmu overexpression on stimulus-evoked arousal using a simple 
behavioral paradigm to evoke both an immediate and delayed arousal response. These results 
suggest that while Nmu can modulate both stimulus-evoked and spontaneous forms of arousal, it 
does so in a manner that heightens and enhances the maintenance of ongoing arousal behavior 
and conversely constricts immediate responses to environmental stimuli. Future studies are 
required to dissect the downstream mechanisms by which Nmu differentially modulates these 
immediate and delayed arousal responses.  
 
A revised model for Nmu signaling mechanisms 
Multiple lines of evidence point to a role for Crh as an essential effector of hyperactivity and 
anorexia of Nmu-treated rodents (Hanada et al., 2001; Hanada et al., 2003). Similarly in 
zebrafish, we found that Nmu-induced hyperactivity is blocked by Crh receptor antagonism. 
Based on the observation that Crh signaling mediates Nmu-induced activity in rodents, it was 
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proposed that Nmu’s effects are mediated by the HPA axis (Hanada et al., 2001). However, the 
requirement for the glucocorticoid receptor (GR), the ultimate effector of Crh signaling in the 
HPA axis, for Nmu-mediated arousal has not been tested. In contradiction to this hypothesis, we 
found that the Nmu overexpression phenotype in zebrafish does not require a functional GR. 
Furthermore, Nmu overexpression does not activate cfos expression in Crh neurons in the 
preoptic area, the zebrafish homolog of the mammalian PVN (Herget et al., 2014). Our results 
suggest that Nmu overexpression does not activate the HPA axis to promote arousal, which 
concords with previous findings in rodents that chronic administration of Nmu does not elevate 
plasma corticosterone levels (Peier et al., 2009), although acute administration of Nmu has been 
reported to increase corticosterone levels (Wren et al., 2002). Furthermore, nmur2 mouse 
mutants do not exhibit abnormal basal or stress-induced corticosterone levels (Peier et al., 2009).  
 
Our data on Nmu-induced cfos expression support a revised model that Nmu-induced sleep/wake 
phenotypes are mediated by HPA/HPI axis-independent, extrahypothalamic Crh neurons (Figure 
8). We found that a Crhr1 antagonist reduced baseline locomotor activity in WT larvae, 
suggesting that Crh signaling is required for normal arousal levels and not just behavioral 
responses to stress. In mammals, Crh signaling regulates both spontaneous and stimulus-evoked 
sleep/wake behaviors (Opp, 1995). Also, alterations in Crh-mediated sleep/wake behavior of 
rodents can occur without affecting corticosterone signaling (Chang and Opp, 2002), and Crh 
administration increases locomotor activity in hypophysectomized rats (Eaves et al., 1985), 
indicating that Crh signaling can regulate arousal independently of the HPA axis. Interestingly, 
the effects of Nmu administration on promoting spontaneous arousal behaviors while reducing 
acute, “stimulus-on” responses in our light flash-evoked assay of zebrafish arousal parallels the 
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roles of Crh in rodents to enhance spontaneous activity but to decrease acute locomotor activity 
responses to novel situations (Koob and Heinrichs, 1999). We found that Nmu overexpression 
results in activation of brainstem Crh nuclei, as well as nuclei in the forebrain. Indeed, Crh is 
expressed in the locus coeruleus and parabrachial nuclei of mammals (Morin et al., 1999), and 
has been shown to directly activate noradrenergic neurons of the locus coeruleus (Jedema and 
Grace, 2004) which in turn send ascending arousal signals to the forebrain (Berridge and 
Waterhouse, 2003). We speculate that Nmu-induced forebrain activation may result from 
activation of Crh neurons participating in the ascending pathways of brainstem arousal nuclei. 
 
In summary, our results identify Nmu as a regulator of sleep/wake behavior in the zebrafish. 
Using a combination of behavioral, genetic, pharmacological, and anatomical approaches, we 
further dissected this neuropeptidergic signaling pathway and propose a novel mechanism for the 
regulation of vertebrate behavioral arousal. More generally, our work establishes an effective and 
efficient genetic screening strategy and provides a community resource for future studies to 
screen for effectors of vertebrate behavior and development. 
 
Experimental Procedures 
Detailed methods are in Supplemental Experimental Procedures. 
 
Behavioral experiments 
Larval zebrafish behavioral experiments were performed and analyzed as described (Prober et 
al., 2006). In brief, 4-5 dpf larva were transferred to 96-well plates and housed inside a custom-
modified Zebrabox (Viewpoint Life Sciences) that was continuously illuminated with infrared 
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lights and illuminated with white lights from 9 a.m. to 11 p.m. The 96-well plate was housed in a 
chamber filled with recirculating water to maintain a constant temperature of 28.5◦C. The 
movement of each larva was measured at 15 Hz and the duration of movement was recorded 
with an integration time of 1 minute for most experiments, except in the arousal assay the 
integration time was 1 second.  
 
Statistical Analyses 
Statistical tests were performed using Matlab and JMP. In all statistical tests, the significance 
threshold was set to p<0.05. Asterisks in figures denote statistics for pairwise comparisons using 
the Steel-Dwass method for multiple comparisons following significant Kruskal-Wallis tests. 
Box plots indicate the median value (solid black line), 25th and 75th percentiles (box), and data 
range (whiskers). “Day” box plots and statistics combine all daytime periods, and “Night” box 
plots and statistics combine all nighttime periods displayed in the corresponding line graph. For 
heat-shock overexpression experiments, box plots and statistics were generated from post-heat 
shock time points. 
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Figure Legends 
Figure 1. A behavioral genetic overexpression screen. (A) The Heat Shock Secretome 
(hs:Sec) overexpression transgenesis cassette. (B) In the primary screen, single cell zebrafish 
embryos were co-injected with the hs:Sec plasmid and tol2 transposase mRNA. Embryos were 
raised to 5 days post-fertilization (dpf) at 28.5oC, a non-permissive temperature for the heat 
shock promoter. (C) A 1 hour, 37oC heat shock (but not the 28.5oC control) treatment induces 
expression of a Secretome gene in hs:Sec/+ larvae, as visualized by in situ hybridization (purple 
stain) in dissected brains. (D) Average activity traces for hs:Hcrt_Dr-injected (n=32) and control 
injected (n=16) larvae. (E) Histogram of all activity indices from the screen, normalized as 
standard deviations from the mean (Z-score). (F) Average activity traces of controls and 
hs:Pnoc_Hs, a previously identified regulator of sleep/wake behavior in zebrafish. (G) Average 
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activity traces of controls and hs:Nmu_Hs, a newly identified regulator of sleep/wake behavior in 
zebrafish. (H) Candidate genes were retested as stable transgenic lines. hs:Nmu_Hs/+ larvae 
generated from a stable transgenic line exhibited increased activity compared to their WT 
siblings. Line plot values are mean±S.E.M. White and black boxes on the x-axis of the line plots 
denote daytime light periods and nighttime dark periods, respectively. Arrows indicate time of 
heat shock (F, G, H). *p<0.05, Mann-Whitney U-test. 
 
Figure 2. The sequence of Nmu and expression of nmu and nmu receptors are conserved in 
zebrafish. (A) The zebrafish predicted Nmu peptide sequence is well conserved with the human 
Nmu mature peptide. The C-terminal heptapeptide and critical residues are indicated by the 
shaded box and asterisks. Amino acids are color coded by type (after Malendowicz et al., 2012): 
blue=basic, red=acidic, green=non-polar, light green=polar. (B-F) Endogenous expression of 
nmu in the hypothalamus (single arrow), brainstem (double arrow), and spinal cord (arrowhead) 
of 24-120 hpf zebrafish. (G, H) Lateral views of nmur1a and nmur2 expression at 48 hpf. (I) 
nmur1a expression in 5 dpf larvae is restricted to the rostro-ventral hypothalamus. (J-L) 
Widespread but discrete expression of nmur2 in 5 dpf zebrafish brain, starting from a ventral 
focal plane (J) and ending in a more dorsal focal plane (L). Note a prominent population of cells 
in the hypothalamus (left/rostral arrow in J) that does not localize to the zebrafish preoptic 
nucleus, which is not visible in this focal plane. Also note several discrete clusters of cells in the 
hindbrain (arrows in L), which are located in the vicinity of brainstem arousal systems such as 
the locus coeruleus. In (G-L), arrows distinguish cellular labeling from diffuse background 
staining. Scale bars=100 µm. 
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Figure 3. Nmu overexpression modulates spontaneous activity, sleep, and stimulus-evoked 
arousal in zebrafish. (A-F) Overexpression of zebrafish Nmu (hs:Nmu_Dr/+, n=44) induces 
hyperactivity and suppresses sleep compared to WT siblings (WT, n=43). (A, B) Line plots of 
mean±S.E.M. show a 48 h recording of 6 dpf larvae raised and tested on a 14:10 h light:dark 
cycle (white and black bars on x-axis, respectively). Arrows indicate time of heat shock. Box 
plots (A’, B’) quantify data from post-heat shock day or night periods. (C-F) Quantification of 
additional sleep parameters from the same dataset. Night sleep architecture is altered in 
hs:Nmu_Dr/+ zebrafish by increased latency to first sleep (C), fewer (D) and shorter (E) sleep 
bouts, and longer wake bouts (F). (G-O) A stimulus-evoked arousal assay reveals two epochs of 
behavioral arousal that are differentially modulated by Nmu overexpression. Measurement of 
baseline, peak amplitude (ypeak – baseline), decay kinetics (τ, single exponential fit), and total 
activity (shaded area) of each response phase are shown for representative WT (G) and 
hs:Nmu_Dr/+ samples (H) during the night following heat shock. (I-O) Box plots show 
quantification of baseline, stimulus-on and post-stimulus response parameters for n=29 samples 
per genotype. In all box plots (A’-F) and (I-O), *p<0.05, **p<0.01, ***p<0.001, Mann-Whitney 
U-test. 
 
Figure 4. nmu is required for normal locomotor activity levels in larval and adult zebrafish. 
nmu-/- larvae exhibit reduced wake activity (A) during the day (A’) but not at night (A’) 
compared to their nmu+/- and nmu+/+ siblings. nmu-/- larvae lack a detectable sleep phenotype 
(B, B’). Three month old nmu-/- adults also exhibit reduced activity compared to their nmu+/- 
siblings (C) during the day (C’) and during night to day transitions (D, D’). Data in adult line 
graphs are averaged in 10 (C) or 1 (D) minute bins. Adult animals were derived from a nmu-/- to 
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nmu+/- mating. Averaged data for all night to day transitions is shown. Number of subjects: (A, 
B) nmu-/- (n=57), nmu+/- (n=82), nmu+/+ (n=51). (C, D) nmu-/- (n=14), nmu+/- (n=15). 
*p<0.05, **p<0.01, ***p<0.001, Kruskal-Wallis test (A’-D’) followed by the Steel-Dwass test 
for pairwise multiple comparisons (A’, B’).  
 
Figure 5. Nmu-induced hyperactivity and insomnia requires nmur2. Nmu overexpression in 
nmur2+/+ larvae (compare red and black traces in A, B) or nmur2+/- larvae (compare yellow and 
brown traces in A, B) increases wake activity (A, A’), suppresses sleep (B, B’), increases latency 
to first sleep at night (C), and induces fewer (D) and shorter (E) sleep bouts, and longer wake 
bouts (F) compared to hs:Nmu_Dr negative siblings in nmur2+/+ and nmur2+/- larvae. In 
contrast, Nmu overexpression has no significant effect on these behavioral parameters in nmur2-
/- larvae (compare cyan and blue traces in A, B, and compare hs:Nmu_Dr positive, red boxes to 
hs:Nmu_Dr negative, black boxes, for each nmur2 genotype in box plots). Arrows indicate time 
of heat shock. Box plots quantify data from post-heat shock day (A’, B’) or night periods (A’, 
B’, C-F). Number of subjects: hs:Nmu/+; nmur2-/- (n=24), hs:Nmu/+; nmur2+/- (n=42), 
hs:Nmu/+; nmur2+/+ (n=25), nmur2-/- (n=13), nmur2+/- (n=39), nmur2+/+ (n=23). *p<0.05, 
***p<0.001, n.s. p>0.05, Kruskal-Wallis test followed by the Steel-Dwass test for pairwise 
multiple comparisons. For hs:Nmu/+ neg. larvae, all comparisons between nmur2-/-, nmur2+/- 
and nmur2+/+ siblings were n.s. (p>0.05). 
 
Figure 6. Nmu overexpression phenotypes do not require a key signaling component of 
HPA axis. Nmu overexpression phenotypes persist in gr-/- larvae. Number of subjects: 
hs:Nmu/+; gr-/- (n=29), hs:Nmu/+; gr+/- (n=46), hs:Nmu/+; gr+/+ (n=29), gr-/- (n=21), gr+/- 
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(n=44), gr+/+ (n=17). *p<0.05, **p<0.01, ***p<0.001, Kruskal-Wallis test followed by the 
Steel-Dwass test for pairwise multiple comparisons. For hs:Nmu/+ neg. larvae, all comparisons 
between gr-/-, gr+/- and gr+/+ siblings were n.s. (p>0.05). 
 
Figure 7. Nmu overexpression activates brainstem crh neurons and the Nmu 
overexpression locomotor phenotype requires Crh receptor 1 signaling. (A) ISH analysis of 
cfos expression one hour after heat-shock induction of Nmu overexpression in a 5 dpf 
hs:Nmu_Dr/+ transgenic zebrafish brain and in an identically treated non-transgenic sibling (B). 
Arrow indicates cfos-expressing brainstem populations. (C, D) Double fluorescent ISH reveals 
brainstem colocalization of cfos and crh expression following Nmu overexpression (dotted box is 
magnified in D), whereas diencephalic crh expression does not colocalize with cfos 
(arrowheads). The brainstem populations in (C) are presented in separate and overlaid confocal 
channels at higher magnification dorsal (D-D”, top) and orthogonal (D-D” bottom) views to 
demonstrate colocalization. (E) Double fluorescent ISH reveals sparse colocalization of nmur2 
and crh expression in the same brainstem populations and in the same views as shown in (D-D”). 
(F) Following Nmu overexpression, some nmur2-expressing cells colocalize with cfos in the 
same brainstem populations and in the same views as shown in (E-E”). Scale bars=100 µm (A-
C) and 20 µm (D, E, F). Images are maximum intensity projections of optical stack thickness = 
300 µm (C), 82 µm (D), 85 µm (E), and 16 µm (F). (G) 5 µM NBI 27914, a Crhr1 antagonist, or 
vehicle (0.05% DMSO) was applied to hs:Nmu_Dr/+ larvae and their WT siblings immediately 
after a 1 h heat shock at 12 p.m. Number of subjects: hs:Nmu_Dr/+, 5 µM NBI 27914 (n = 40), 
WT, 5 µM NBI 27914 (n = 55), hs:Nmu_Dr/+, DMSO (n = 47), WT, DMSO (n = 49). (H) 
Additional experiments performed at 2 µM and 0.5 µM NBI 27914 reveal dose-dependent 
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inhibition of the Nmu overexpression phenotype. Data were normalized by dividing the average 
post-HS Day waking activity of each fish by the mean value of within-experiment WT vehicle 
samples. Normalized values from individual samples across separate experiments were then 
pooled for analysis and box plots. Number of subjects: hs:Nmu_Dr/+, NBI 27914: 5 µM (n = 
40), 2 µM (n = 25), 0.5 µM (n = 35), DMSO (n= 101); WT, NBI 27914: 5 µM (n = 55),  2 µM (n 
= 23), 0.5 µM (n = 32), DMSO (n = 103). *p<0.05, **p<0.01, n.s. p>0.05, Kruskal-Wallis test 
followed by the Steel-Dwass test for pairwise multiple comparisons. 
 
Figure 8. Newly tested and revised hypotheses of Nmu signaling in sleep/wake behavior. (A) 
Rodent studies propose that Nmu-induced behavioral phenotypes are mediated by Crh neurons in 
the paraventricular nucleus of the hypothalamus (PVN). The PVN is the starting point of the 
hypothalamic-pituitary-adrenal (HPA) axis, in which binding of glucocorticoids to the 
glucocorticoid receptor (GR) is the final step of the HPA signaling cascade. (B) Our experiments 
in zebrafish show a conserved functional Nmu/Nmur2/Crh signaling pathway but contradict a 
role for HPA/HPI axis in zebrafish Nmu signaling by demonstrating that Nmu’s actions do not 
require the GR. We put forth the revised hypothesis that Nmu-induced arousal phenotypes are 
mediated by extra-hypothalamic sources of Crh that participate in brainstem arousal systems, 
such as the locus coeruleus (LC) and parabrachial nucleus (PB). We also show that Nmu and 
Nmur1a are required for the normal growth of adult zebrafish. 
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Supplemental Text & Figures
A!
B!
ATGGAGATTGAAGACTTCTGCCTTGACCAAGACGAGTATCTGGAGAAATACCTCGGGCCAAGACGATCCCCAGTGTTCCTGCCTGTAT 88Nmur1a_Dr
ATGGAGATTGAAGACTTCTGCCTTGACCAAGACGAGTATCTGGAGAAATACCTCGGGCCAAGACGATCCCCAGTGTTCCTGCCTGTAT 88Nmur1a_Dr i11
GCCTGACCTACCTCCTGATCTTCCTGGTGGGAGCGGTGGGAAACATCCTTACCTGCATTGTCATTGCTAAAAACAAAGTCATGCGGAC 176Nmur1a_Dr
GCCTGACCTACCTCCTGATCTTCCTGGTGGGAGCGGTGGGAAACATCCTTACCTGCATTGTCATTGCTAAAAACAAAGTCATGCGGAC 176Nmur1a_Dr i11
GCCGACCAACTTCTACCTGTTCAGCCTGGCCATTTCAGATCTTCTAGTGCTTCTCCTGGGAATGCCTTTGGAGCTTTATGAAATGTGG 264Nmur1a_Dr
GCCGACCAACTTCTACCTGTTCAGCCTGGCCATTTCAGATCTTCTAGTGCTTCTCCTGGGAATGCCTTTGGAGCTTTATGAAATGTGG 264Nmur1a_Dr i11
AGCAACTATCCGTTCCTTTTAGGCAAGGGCGGTTGTTACTTCAAGACTCTTCTCTTCGAGACTGTTTGCTTTGCGTCGATCTTGAACG 352Nmur1a_Dr
AGCAACTATCCGTTCCTTTTAGGCAAGGGCGGTTGTTACTTCAAGACTCTTCTCTTCGAGACTGTTTGCTTTGCGTCGATCTTGAACG 352Nmur1a_Dr i11
TAACTGCTTTGAGCGTTGAACGCTACATTGCTGTGATTCACCCACTCCGAGCCAAATACGTAGTAACCCGCACTCATGCAAAGCGCCT 440Nmur1a_Dr
TAACTGCTTTGAGCGTTGAACGCTACATTGCTGTGATTCACCCACTCCGAGCCAAATACGTAGTAACCCGCACTCATGCAAAGCGCCT 440Nmur1a_Dr i11
GATATTGAGCGTCTGGAGCATTTCCGTGCTTTGCGCCATTCCCAACACGATCCTCCACGGTATATTTACTCTCCCGCCTCCTAAAGGG 528Nmur1a_Dr
GATATTGAGCGTCTGGAGCATTTCCGTGCTTTGCGCCATTCCCAACACGATCCTCCACGGTATATTTACTCTCCCGCCTCCTAAAGGG 528Nmur1a_Dr i11
AAAGCAGCAGGAGTCATGCTCGACTCCGCCACATGCATGCTCGTGAAACCGCGCTGGATGTACAACCTGATCATCCAAATCACGACTC 616Nmur1a_Dr
AAAGCAGCAGGAGTCATGCTCGACTCCGCCACATGCATGCTCGTGAAACCGCGCTGGATGTACAACCTGATCATCCAAATCACGACTC 616Nmur1a_Dr i11
TGCTATTCTTCCTGTTGCCCATGTTGACCATCAGCGTTTTGTATCTGCTCATCGGCATGCAGCTGAAGCGGGAGAAGATGCTGCAGGT 704Nmur1a_Dr
TGCTATTCTTCCTGTTGCCCATGTTGACCATCAGCGTTTTGTATCTGCTCATCGGCATGCAGCTGAAGCGGGAGAAGATGCTGCAGGT 704Nmur1a_Dr i11
CCTGGAGGCCAAAGCCAGTTCGGGCCTGGACAGCTCATCTAATGTGCGCAGTCAGCAGCAGAAAACCCGTCGCCAGCAGGTGACCAAG 792Nmur1a_Dr
CCTGGAGGCCAAAGCCAGTTCGGGCCTGGACAGCTCATCTAATGTGCGCAGTCAGCAGCAGAAAACCCGTCGCCAGCAGGTGACCAAG 792Nmur1a_Dr i11
ATGTTGTTTGTTTTGGTGGTGATGTTCGGCATCTGCTGGGCTCCGTTTCACACCGACCG-----------CCTGATGTGGAGCTTCAT 869Nmur1a_Dr
ATGTTGTTTGTTTTGGTGGTGATGTTCGGCATCTGCTGGGCTCCGTTTCACACCGACCGGTTTCGCTAGCTCCGATGTGGAGCTTCAT 880Nmur1a_Dr i11
GGATCAGAAGGACAGCGAGCACATCGAGATCTTTGAGGTCTACGAGTACGTCCACGTCATCTCCGGGGTCTTTTTCTACCTGAGCTCG 957Nmur1a_Dr
GGATCAGAAGGACAGCGAGCACATCGAGATCTTTGAGGTCTACGAGTACGTCCACGTCATCTCCGGGGTCTTTTTCTACCTGAGCTCG 968Nmur1a_Dr i11
GCCATAAACCCCGTCCTCTACAATCTGATGTCCACCCGCTTCAGGGAGATGTTCAAAGAGGTGATGTGCCACCATAAATGGCGTCCCG 1045Nmur1a_Dr
GCCATAAACCCCGTCCTCTACAATCTGATGTCCACCCGCTTCAGGGAGATGTTCAAAGAGGTGATGTGCCACCATAAATGGCGTCCCG 1056Nmur1a_Dr i11
TCCCGAGAAAGCGCTCTCTGAGCATGACCAGAGTCACCGTTCGCAGCACCGTCAGTGACGTCCCGCCATGCAACGGCACTGTGACTAT 1133Nmur1a_Dr
TCCCGAGAAAGCGCTCTCTGAGCATGACCAGAGTCACCGTTCGCAGCACCGTCAGTGACGTCCCGCCATGCAACGGCACTGTGACTAT 1144Nmur1a_Dr i11
TGAAGGAGACGATTATGACGTGGATGAAGGTCAAGAAAATAAGACATGTCCCTAA 1188Nmur1a_Dr
TGAAGGAGACGATTATGACGTGGATGAAGGTCAAGAAAATAAGACATGTCCCTAA 1199Nmur1a_Dr i11
C!
ATGAGGAACAGCAATCAATGTGAACGCGCAACCGCTCACAGCGCGATGAGCCCGGGAAACACCTCCGCCCTGATGCTCGC 80Nmu_Dr
ATGAGGAACAGCAATCAATGTGAACGCGCAACCGCTCACAGCGCGATGAGCCCGGGAAACACCTCCGCCCT----CTCGC 76Nmu_Dr d4
GGTACTACTCCTCTCCTTCATACCCATCACCACAAGTGCTCCGATGCTCTTGAATCCATCTTCACTAGAGCATGAGCAGC 160Nmu_Dr
GGTACTACTCCTCTCCTTCATACCCATCACCACAAGTGCTCCGATGCTCTTGAATCCATCTTCACTAGAGCATGAGCAGC 156Nmu_Dr d4
TACTAACCCAGATAACTGATTTGTGTTCATTCTACCTCTCCGCAGACCCGTCCTTTAGAACATCTGACGTCCTGGAGGAC 240Nmu_Dr
TACTAACCCAGATAACTGATTTGTGTTCATTCTACCTCTCCGCAGACCCGTCCTTTAGAACATCTGACGTCCTGGAGGAC 236Nmu_Dr d4
CTGTGTTTCCTAATGCTGGGATCACTGCAAAAATCGAAGGAGATCACAGCTCGAGAGACTAGCAAAAGGTTTTTATTTCA 320Nmu_Dr
CTGTGTTTCCTAATGCTGGGATCACTGCAAAAATCGAAGGAGATCACAGCTCGAGAGACTAGCAAAAGGTTTTTATTTCA 316Nmu_Dr d4
TTACACTAAACCAAACGGGGCAGGATTGTCTGATGGGACGTCTACTGTGTTGCACCCTCTTCTGGAGCTCATACCCCAGC 400Nmu_Dr
TTACACTAAACCAAACGGGGCAGGATTGTCTGATGGGACGTCTACTGTGTTGCACCCTCTTCTGGAGCTCATACCCCAGC 396Nmu_Dr d4
TTGCCAGAAGAAGAAGCAGGAGAATGAAATTAAATGAGAACCTTCAAGGTCCGGGACGCATCCAGAGCAGAGGATACTTC 480Nmu_Dr
TTGCCAGAAGAAGAAGCAGGAGAATGAAATTAAATGAGAACCTTCAAGGTCCGGGACGCATCCAGAGCAGAGGATACTTC 476Nmu_Dr d4
CTTTATCGGCCAAGAAATGGAAGAAGATCTGATGAGTATGTGTAA 525Nmu_Dr
CTTTATCGGCCAAGAAATGGAAGAAGATCTGATGAGTATGTGTAA 521Nmu_Dr d4
MLRTESCRPRSPAGQVAAA--SPLLLLLLLLAWCAGACRGAPIL-PQGLQPEQQLQLWNEIDDTCSSFLSIDSQPQASNALEELCFMIM 86Nmu_Hs
MSRAAGHRPGLSAGQLAAATASPLLSLLLLLACCADACKGVPIS-PQRLQPEQELQLWNEIHEACASFLSIDSRPQASVALRELCRIVM 88Nmu_Mm
MRNSNQCERATAHSAMSPGNTSALMLAVLLLSFIPITTSAPMLLNPSSLEHEQ---LLTQITDLCSFYLSADPSFRTSDVLEDLCFLML 86Nmu_Dr
MRNSNQCERATAHSAMSPGNTSALSRYYSSPSYPSPQVLRCS 42Nmu_Dr d4
GMLPKPQEQDEKDNTKRFLFHYSKTQKLGKSNVVSSVVHPLLQLVPHLHERRMKRFRVDEEFQSPFASQSRGYFLFRPRNGRRSAGFI 174Nmu_Hs
EISQKPQEQSEKDNTKRFLFHYSKTQKLGNSNVVSSVVHPLLQLVPQLHERRMKRFKA--EYQSPSVGQSKGYFLFRPRNGKRSTSFI 174Nmu_Mm
GSLQKSKEITARETSKRFLFHYTKPNGAGLSDGTSTVLHPLLELIPQLARRRSRRMKLNENLQGPGRIQSRGYFLYRPRNGRRSDEYV 174Nmu_Dr
42Nmu_Dr d4
*	   *	  
Figure S2
2
ATGATACAGTACAACTGCTCCTCTCCAAGTTCACTGTTCACAGTTGTTGTGAACACGTCATGGTGCTCCACCAAAGAAGAAGAATGT 87Nmur1b_Dr
ATGATACAGTACAACTGCTCCTCTCCAAGTTCACTGTTCACAGTTGTTGTGAACACGTCATGGTGCTCCACCA-----GAAGAATGT 82Nmur1b_Dr d5
CAAAACAGAACAGCAAACCTATCAGACCTCTGTCTATCCCGCAGTGCCTACCTGGAGAAATACCTTGGACCCTGTCGTTCACCTTTC 174Nmur1b_Dr
CAAAACAGAACAGCAAACCTATCAGACCTCTGTCTATCCCGCAGTGCCTACCTGGAGAAATACCTTGGACCCTGTCGTTCACCTTTC 169Nmur1b_Dr d5
TTTCTGCCTATATGTGTCACCTACCTGCTCATCTTTGTAGTAGGTGTGGTGGGCAACATCCTAACTTGTATTGTCATTACCCGTCAT 261Nmur1b_Dr
TTTCTGCCTATATGTGTCACCTACCTGCTCATCTTTGTAGTAGGTGTGGTGGGCAACATCCTAACTTGTATTGTCATTACCCGTCAT 256Nmur1b_Dr d5
CGCATCATGCGCACAACGACAAACTACTACCTGTTCAGCCTGGCCATTTCTGACCTCCTTGTGCTGTTGCTTGGCCTCCCGCTGGAG 348Nmur1b_Dr
CGCATCATGCGCACAACGACAAACTACTACCTGTTCAGCCTGGCCATTTCTGACCTCCTTGTGCTGTTGCTTGGCCTCCCGCTGGAG 343Nmur1b_Dr d5
CTTTATGAGCTCTGGAGCAACTATCCTTTTCTGTTTGGAATTTCTGGCTGCTACTTCAAAACCTGTCTCTTTGAGACAGTCTGCTTT 435Nmur1b_Dr
CTTTATGAGCTCTGGAGCAACTATCCTTTTCTGTTTGGAATTTCTGGCTGCTACTTCAAAACCTGTCTCTTTGAGACAGTCTGCTTT 430Nmur1b_Dr d5
GCCTCTGTTCTCAATGTTACAGCCTTAAGTGCAGAACGTTATAGAGCTATCATTCATCCTCTGCACACCAAACATGTTGCGACGAGT 522Nmur1b_Dr
GCCTCTGTTCTCAATGTTACAGCCTTAAGTGCAGAACGTTATAGAGCTATCATTCATCCTCTGCACACCAAACATGTTGCGACGAGT 517Nmur1b_Dr d5
GCTCATGCAAAGCGTGTTATCCTTGTGTTATGGGCTGTCTCTCTATTGTGTGCCTTGCCCAATACCAGTATTCATGGTGTGGAGATG 609Nmur1b_Dr
GCTCATGCAAAGCGTGTTATCCTTGTGTTATGGGCTGTCTCTCTATTGTGTGCCTTGCCCAATACCAGTATTCATGGTGTGGAGATG 604Nmur1b_Dr d5
TTAAAACCCCGTTTTGGACTTACTTTCCCAGAATCAGGTGTGTGTACAGTGGTACACGATAGGTGGATCTACAACCTGCTGGTGCAA 696Nmur1b_Dr
TTAAAACCCCGTTTTGGACTTACTTTCCCAGAATCAGGTGTGTGTACAGTGGTACACGATAGGTGGATCTACAACCTGCTGGTGCAA 691Nmur1b_Dr d5
GTGACAGCACTGCTGTTCTTCATACTGCCGATGCTGACTATCAGTGTGCTGTATGTGCTGATTGGCCTACAGCTGCACCGGGAAAGG 783Nmur1b_Dr
GTGACAGCACTGCTGTTCTTCATACTGCCGATGCTGACTATCAGTGTGCTGTATGTGCTGATTGGCCTACAGCTGCACCGGGAAAGG 778Nmur1b_Dr d5
GAGTGCTTTGATTCAAAGATCGTGCTCAATCAGGATGGGGTCAATCAGAGGGCACGTCATCGACAAGTCACAAAAATGCTTTGTGCA 870Nmur1b_Dr
GAGTGCTTTGATTCAAAGATCGTGCTCAATCAGGATGGGGTCAATCAGAGGGCACGTCATCGACAAGTCACAAAAATGCTTTGTGCA 865Nmur1b_Dr d5
TTGGTGATTGTGTTTGGAATCTGCTGGGCTCCCTTTCACATTGATCGTGTAATGTGGAGCTATATTGATGACTGGACTGCAGAGAAC 957Nmur1b_Dr
TTGGTGATTGTGTTTGGAATCTGCTGGGCTCCCTTTCACATTGATCGTGTAATGTGGAGCTATATTGATGACTGGACTGCAGAGAAC 952Nmur1b_Dr d5
CACCACATCTTTGAGTATGTGCATCTTCTATCTGGTGTCTTCTTCTACTTGAGCTCAGTGGTCAATCCCATCCTGTATAACCTCATG 1044Nmur1b_Dr
CACCACATCTTTGAGTATGTGCATCTTCTATCTGGTGTCTTCTTCTACTTGAGCTCAGTGGTCAATCCCATCCTGTATAACCTCATG 1039Nmur1b_Dr d5
TCTTCGCGCTTCAGAGAAATGTTCCGTGAGGTGGTGTGTCAAAAAGACCATCGTCAGCTCTCAATGAGTAGGGTCACATTACGTAGT 1131Nmur1b_Dr
TCTTCGCGCTTCAGAGAAATGTTCCGTGAGGTGGTGTGTCAAAAAGACCATCGTCAGCTCTCAATGAGTAGGGTCACATTACGTAGT 1126Nmur1b_Dr d5
GTTGTTTCTGCCTCTTTTTCTGCCTCCAATACAGTCTCATTTTCTGTAAAGTTCAACCCACGTGAGCTGCCACACACACTC      1212Nmur1b_Dr
GTTGTTTCTGCCTCTTTTTCTGCCTCCAATACAGTCTCATTTTCTGTAAAGTTCAACCCACGTGAGCTGCCACACACACTC      1207Nmur1b_Dr d5
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MTPLCLNCSVLPGDLYPGGARNPMACNGSAA---RGHFDPEDLNLTDEALRLKYLGPQQTELFMPICATYLLIFVVGAVGNGLTCLVI 85Nmur1_Hs
MV-----------------------CNISEF---KWPYQPEDLNLTDEALRLKYLGPQQMKQFVPICVTYLLIFVVGTLGNGLTCTVI 62Nmur1_Mm
M-------------------------------------EIEDFCLDQDEYLEKYLGPRRSPVFLPVCLTYLLIFLVGAVGNILTCIVI 51Nmur1a_Dr
M-------------------------------------EIEDFCLDQDEYLEKYLGPRRSPVFLPVCLTYLLIFLVGAVGNILTCIVI 51Nmur1a_Dr i11
MIQY--NCSS-PSSLFTVVVNTSW-CSTKEEECQNRTANLSDLCLSRSAYLEKYLGPCRSPFFLPICVTYLLIFVVGVVGNILTCIVI 84Nmur1b_Dr
MIQY--NCSS-PSSLFTVVVNTSW-CSTRRMSKQNSKPIRPLSIPQCLPGEIPWTLSFTFLSAYMCHLPAHLCSRCGGQHPNLYCHYP 84Nmur1b_Dr d5
LRHKAMRTPTNYYLFSLAVSDLLVLLVGLPLELYEMWHNYPFLLGVGGCYFRTLLFEMVCLASVLNVTALSVERYVAVVHPLQARSMV 173Nmur1_Hs
LRNKTMRTPTNFYLFSLAVSDMLVLLVGLPLELYEMQQNYPFQLGASACYFRILLLETVCLASVLNVTALSVERYVAVVRPLQAKSVM 150Nmur1_Mm
AKNKVMRTPTNFYLFSLAISDLLVLLLGMPLELYEMWSNYPFLLGKGGCYFKTLLFETVCFASILNVTALSVERYIAVIHPLRAKYVV 139Nmur1a_Dr
AKNKVMRTPTNFYLFSLAISDLLVLLLGMPLELYEMWSNYPFLLGKGGCYFKTLLFETVCFASILNVTALSVERYIAVIHPLRAKYVV 139Nmur1a_Dr i11
TRHRIMRTTTNYYLFSLAISDLLVLLLGLPLELYELWSNYPFLFGISGCYFKTCLFETVCFASVLNVTALSAERYRAIIHPLHTKHVA 172Nmur1b_Dr
SSHHAHNDKLLPVQPGHF 102Nmur1b_Dr d5
TRAHVRRVLGAVWGLAMLCSLPNTSLHGIRQLHVP---CRGPVPDSAVCMLVRPRALYNMVVQTTALLFFCLPMAIMSVLYLLIGLRL 258Nmur1_Hs
TRAHVRRMVGAIWVLATLFSLPNTSLHGLSQLTVP---CRGPVPDSAICSLVGPMDFYKLVVLTTALLFFCLPMVTISVLYLLIGLRL 235Nmur1_Mm
TRTHAKRLILSVWSISVLCAIPNTILHGIFTLPPPKGKAAGVMLDSATCMLVKPRWMYNLIIQITTLLFFLLPMLTISVLYLLIGMQL 227Nmur1a_Dr
TRTHAKRLILSVWSISVLCAIPNTILHGIFTLPPPKGKAAGVMLDSATCMLVKPRWMYNLIIQITTLLFFLLPMLTISVLYLLIGMQL 227Nmur1a_Dr i11
TSAHAKRVILVLWAVSLLCALPNTSIHGVEMLKPRFGLT---FPESGVCTVVHDRWIYNLLVQVTALLFFILPMLTISVLYVLIGLQL 257Nmur1b_Dr
102Nmur1b_Dr d5
RRERLLLMQEAKGRGSAAARSRYTCRLQQHDRGRRQVTKMLFVLVVVFGICWAPFHADRVMWSVV-SQWTDGLHL--AFQHVHVISGI 343Nmur1_Hs
RRERMLLQVEVKGRKTAATQETSHRRIQLQDRGRRQVTKMLFALVVVFGICWAPFHADRIMWSLVYGHSTEGLHL--AYQCVHIASGI 321Nmur1_Mm
KREKMLQVLEAKA--SSGLDSSSNVRSQQQKTRRQQVTKMLFVLVVMFGICWAPFHTDRLMWSFMDQKDSEHIEIFEVYEYVHVISGV 313Nmur1a_Dr
KREKMLQVLEAKA--SSGLDSSSNVRSQQQKTRRQQVTKMLFVLVVMFGICWAPFHTDRFR 286Nmur1a_Dr i11
HRER--ECFDSKI--VLNQDGVN------QRARHRQVTKMLCALVIVFGICWAPFHIDRVMWSYIDDWTAENHHIFE---YVHLLSGV 332Nmur1b_Dr
102Nmur1b_Dr d5
FFYLGSAANPVLYSLMSSRFRETFQEALCLGA-CCHRLRPRHSSHSLSRMTTGSTLCDVGSLGSWVHPLAGN-DGPEAQQETDPS   426Nmur1_Hs
FFYLGSAANPVLYSLMSTRFRETFLQALGLGTQCCHRRQPYHGSHNHIRLTTGSTLCDVGHRNSRDEPLAVN-EDPGCQQETDPS   405Nmur1_Mm
FFYLSSAINPVLYNLMSTRFREMFKEVMCHHK---WRPVPRKRSLSMTRVTVRSTVSDVPPCNGTVTIEGDDYDVDEGQENKTCP   395Nmur1a_Dr
286Nmur1a_Dr i11
FFYLSSVVNPILYNLMSSRFREMFREVVCQKD---------HRQLSMSRVTLRSVVSASFSASNTVSF-SVKFNPRELPHTL      404Nmur1b_Dr
102Nmur1b_Dr d5
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ATGATGGCCCTGATCTGCCTTTGCGAGTCTGTGAATACATCAGACCAGGATTATGAGTTCTGCAACAGCAGTACGTTCAACTTCACTGG 89Nmur2_Dr
ATGATGGCCCTGATCTGCCTTTGCGAGTCTGTGAATACATCAGACCAGGATTATGAGTTCTGCAACAGCAGTACGTTCAACTTCACTGG 89Nmur2_Dr d17
AAATGACAGTGCACACTGTTACCTTCAGACCATTGATGAAGTTCTGTTTAAGCTTCTGGGCCCAAGACGATCTCCGTTCTTCTTCCCTG 178Nmur2_Dr
AAATGACAGTGCACACTGTTACCTTCAGACCATTGATGAAGTTCTGTTTAAGCTTCTGGGCCCAAGACGATCTCCGTTCTTCTTCCCTG 178Nmur2_Dr d17
TAACCTGTACTTACATCCTCATCTTCATGACCGGGGTCTTAGGAAACCTCCTGACCTGCGCTGTAATCACTAAAGATCGAAAAATGCAA 267Nmur2_Dr
TAACCTGTACTTACATCCTCATCTTCATGACCGGGGTCTTAGGAAACCTCCTGACCTGCGCTGTAATCACTAAAGATCGAAAAATGCAA 267Nmur2_Dr d17
ACTCCCACCAACTTGTATCTCTTTAGCCTGGCCATCTCCGATCTTCTAGTGCTACTCTTCGGGATGCCTCTGGAAATCTACGAACTTTG 356Nmur2_Dr
ACTCCCACCAACTTGTATCTC-----------------CGATCTTCTAGTGCTACTCTTCGGGATGCCTCTGGAAATCTACGAACTTTG 339Nmur2_Dr d17
GCAAAACTACCCTTTTCCCTTCGGCGAGAGCATCTGCTGCTTTAAAATCTTCTTGTTCGAAACAGTTTGCTTTGCTTCCGTGTTAAACG 445Nmur2_Dr
GCAAAACTACCCTTTTCCCTTCGGCGAGAGCATCTGCTGCTTTAAAATCTTCTTGTTCGAAACAGTTTGCTTTGCTTCCGTGTTAAACG 428Nmur2_Dr d17
TCACAGTGCTAAGTGTGGAGCGATACATAGCTGTGATTCACCCGCTCAAAACCCGTTACGCCATCACCAACAAGCACGCTCGAAGGGTC 534Nmur2_Dr
TCACAGTGCTAAGTGTGGAGCGATACATAGCTGTGATTCACCCGCTCAAAACCCGTTACGCCATCACCAACAAGCACGCTCGAAGGGTC 517Nmur2_Dr d17
ATCGCTGGGGTTTGGGCTATGTCTCTGCTCTGCGCCGTCCCGAACACCTCCCTCCATGGCCTGCAGTATCAGTATCTGCCGGAGAGGGT 623Nmur2_Dr
ATCGCTGGGGTTTGGGCTATGTCTCTGCTCTGCGCCGTCCCGAACACCTCCCTCCATGGCCTGCAGTATCAGTATCTGCCGGAGAGGGT 606Nmur2_Dr d17
TCAGGAATCGGCTACCTGCAACCTGCTCAAGCCCAAATGGATGTACAACTTGGTGATCCAGATCACAACTGTGCTCTTCTACTTTGTTC 712Nmur2_Dr
TCAGGAATCGGCTACCTGCAACCTGCTCAAGCCCAAATGGATGTACAACTTGGTGATCCAGATCACAACTGTGCTCTTCTACTTTGTTC 695Nmur2_Dr d17
CCATGATGATGATCAGCGTGCTGTATCTGATGATCGGTCTGACGCTTGGCAGAGGGCAGAAGCAGAAAAAGGACAAGCTGGGAAGCAAT 801Nmur2_Dr
CCATGATGATGATCAGCGTGCTGTATCTGATGATCGGTCTGACGCTTGGCAGAGGGCAGAAGCAGAAAAAGGACAAGCTGGGAAGCAAT 784Nmur2_Dr d17
CACAGCAACGACAGCTGGAAAATCCATCTGGACAGCAGACGGAGAAGGCAGGTCACCAAGATGCACTTTGTGGTGGTATTAGTGTTTGC 890Nmur2_Dr
CACAGCAACGACAGCTGGAAAATCCATCTGGACAGCAGACGGAGAAGGCAGGTCACCAAGATGCACTTTGTGGTGGTATTAGTGTTTGC 873Nmur2_Dr d17
CATCTGCTGGGCTCCGTTCCACATCGACCGGCTCTTATGGAGCTTCATCACCAGTTGGACAGACCACATGCATAACATCTTTGAATATG 979Nmur2_Dr
CATCTGCTGGGCTCCGTTCCACATCGACCGGCTCTTATGGAGCTTCATCACCAGTTGGACAGACCACATGCATAACATCTTTGAATATG 962Nmur2_Dr d17
TGCACATAATCTCCGGCGTGCTCTTCTACCTCAGTTCAGCTGTAAACCCCATAATCTACAACCTGCTTTCCAGCCGCTTCCGGGAACGG 1068Nmur2_Dr
TGCACATAATCTCCGGCGTGCTCTTCTACCTCAGTTCAGCTGTAAACCCCATAATCTACAACCTGCTTTCCAGCCGCTTCCGGGAACGG 1051Nmur2_Dr d17
TTTCAAGCGCTGGTGTGCAGTCGCCTGTCAACTAGATCCTCACGTAATGATTCCATGCCTTTTTACATCATACCCAAAGACCCCCCGAC 1157Nmur2_Dr
TTTCAAGCGCTGGTGTGCAGTCGCCTGTCAACTAGATCCTCACGTAATGATTCCATGCCTTTTTACATCATACCCAAAGACCCCCCGAC 1140Nmur2_Dr d17
TGATTTCAAACGGACTGGA 1176Nmur2_Dr
TGATTTCAAACGGACTGGA 1159Nmur2_Dr d17
F!
MSGM----EKLQNA--------SWIYQQKLEDPFQKHLNSTEEYLAFLCGPRRSHFFLPVSVVYVPIFVVGVIGNVLVCLVILQHQAMK 77Nmur2_Hs
MG-------KLENA--------SWI-----HDSLMKYLNSTEEYLAYLCGPKRSDLSLPVSVVYALIFVVGVIGNLLVCLVIARHQTLK 69Nmur2_Mm
MMALICLCESVNTSDQDYEFCNSSTFNFTGNDSAHCYLQTIDEVLFKLLGPRRSPFFFPVTCTYILIFMTGVLGNLLTCAVITKDRKMQ 89Nmur2_Dr
MMALICLCESVNTSDQDYEFCNSSTFNFTGNDSAHCYLQTIDEVLFKLLGPRRSPFFFPVTCTYILIFMTGVLGNLLTCAVITKDRKMQ 89Nmur2_Dr d17
TPTNYYLFSLAVSDLLVLLLGMPLEVYEMWRNYPFLFGPVGCYFKTALFETVCFASILSITTVSVERYVAILHPFRAKLQSTRRRALRI 166Nmur2_Hs
TPTNYYLFSLAVSDLLVLLLGMPLEVYELWHNYPFLFGPVGCYFKTALFETVCFASILSVTTVSIERYVAIVHPFRAKLESTRRRALRI 158Nmur2_Mm
TPTNLYLFSLAISDLLVLLFGMPLEIYELWQNYPFPFGESICCFKIFLFETVCFASVLNVTVLSVERYIAVIHPLKTRYAITNKHARRV 178Nmur2_Dr
TPTNLYLRSSSATLRDASGNLRTLAKLPFSLRREHLLL 127Nmur2_Dr d17
LGIVWGFSVLFSLPNTSIHGIKFHYFPNGSLVPGSATCTVIKPMWIYNFIIQVTSFLFYLLPMTVISVLYYLMALRLKKDKSLEADEG- 254Nmur2_Hs
LSLVWSFSVVFSLPNTSIHGIKFQQFPNGSSVPGSATCTVTKPIWVYNFIIQATSFLFYILPMTLISVLYYLMGLRLKRDESLEADKV- 246Nmur2_Mm
IAGVWAMSLLCAVPNTSLHGLQYQYLPE--RVQESATCNLLKPKWMYNLVIQITTVLFYFVPMMMISVLYLMIGLTLGRGQKQKKDKLG 265Nmur2_Dr
127Nmur2_Dr d17
--------NANIQRPCRKSVNKMLFVLVLVFAICWAPFHIDRLFFSFVEEWSESLAAVFNLVHVVSGVFFYLSSAVNPIIYNLLSRRFQ 335Nmur2_Hs
--------TVNIHRPSRKSVTKMLFVLVLVFAICWTPFHVDRLFFSFVDEWTESLAAVFNLIHVVSGVFFYLSSAVNPIIYNLLSRRFR 327Nmur2_Mm
SNHSNDSWKIHLDSRRRRQVTKMHFVVVLVFAICWAPFHIDRLLWSFITSWTDHMHNIFEYVHIISGVLFYLSSAVNPIIYNLLSSRFR 354Nmur2_Dr
127Nmur2_Dr d17
AAFQNVISSFHKQW-HSQHDPQLPPAQRNIFLTECHFVELTEDIGPQFPCQSSMHNSHLPAALSSEQMSRTNYQSFHFNKT 415Nmur2_Hs
AAFRNVVSPSCK-WCHPQHRPQGPPAQKVIFLTECHLVELTEDAGPQFPCQSSIHNTQLTTVPCVEEVP                    395Nmur2_Mm
ERFQALVCSRLSTRS-SRNDS-MPFY--IIPK-----DPPT-DFKRTG                                         392Nmur2_Dr
127Nmur2_Dr d17
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Table	  S1.	  Primary	  Screen
1432
1286
1126
146
306
768
660
72
13
hs:Hcrt
hs:EGFP
Experiments	  Performed
Unique	  ORFs
Unique	  Genes
Duplicate	  ORFs
Duplicate	  Genes
Controls
empty	  hs	  vector
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Table	  S2.	  Primary	  Screen	  Raw	  Data
Screen	  Data Control	  Data
Sleep	  (min/h) Mean	  +/-­‐	  SD Mean	  +/-­‐	  SD
Pre-­‐HS
Night 34.0	  +/-­‐	  5.3 34.9	  +/-­‐	  5.3
Day 18.1	  +/-­‐	  5.6 18.3	  +/-­‐	  6.1
Post-­‐HS
Day	  1 15.7	  +/-­‐	  4.7 16.0	  +/-­‐	  4.9
Night 21.9	  +/-­‐	  4.5 23.0	  +/-­‐	  4.5
Day	  2 14.0	  +/-­‐	  4.5 14.7	  +/-­‐	  4.9
Sleep	  Bouts	  (#/h)
Pre-­‐HS
Night 7.8	  +/-­‐	  1.0 7.8	  +/-­‐	  1.02
Day 4.71	  +/-­‐	  1.1 4.8	  +/-­‐	  1.1
Post-­‐HS
Day	  1 3.9	  +/-­‐	  0.9 3.9	  +/-­‐	  1.7
Night 7.6	  +/-­‐	  1.2 7.7	  +/-­‐	  1.2
Day	  2 5.7	  +/-­‐	  1.4 6.1	  +/-­‐	  1.5
Sleep	  Bout	  Length	  (min/bout)
Pre-­‐HS
Night 4.9	  +/-­‐	  1.6 5.2	  +/-­‐	  1.9
Day 4.0	  +/-­‐	  1.2 4.0	  +/-­‐	  1.5
Post-­‐HS
Day	  1 5.0	  +/-­‐	  5.2 4.9	  +/-­‐	  2.8
Night 3.0	  +/-­‐	  0.9 3.1	  +/-­‐	  1.4
Day	  2 2.4	  +/-­‐	  1.2 2.7	  +/-­‐	  6.0
Sleep	  Latency	  (min)
Pre-­‐HS
Night 26.2	  +/-­‐	  10.0 25.4	  +/-­‐	  10.6
Day 54.6	  +/-­‐	  32.6 56.4	  +/-­‐	  33.2
Post-­‐HS
Day	  1 N/A N/A
Night 60.8	  +/-­‐	  25.0 55.2	  +/-­‐	  24.4
Day	  2 101.6	  +/-­‐	  43.6 99.0	  +/-­‐	  52.0
Average	  Activity	  (s/h)
Pre-­‐HS
Night 48.4	  +/-­‐	  12.5 43.9	  +/-­‐	  11.4
Day 240.6	  +/-­‐	  49.9 218	  +/-­‐	  47.9
Post-­‐HS
Day	  1 257.0	  +/-­‐	  49.1 230.8	  +/-­‐	  47.0
Night 66.2	  +/-­‐	  15.1 59.1	  +/-­‐	  12.9
Day	  2 213.5	  +/-­‐	  43.3 183.7	  +/-­‐	  42.8
Wake	  Activity	  (s/h)
Pre-­‐HS
Night 108	  +/-­‐	  18 102	  +/-­‐	  18
Day 342	  +/-­‐	  54	   312	  +/-­‐	  54
Post-­‐HS
Day	  1 348	  +/-­‐54 312	  +/-­‐	  48
Night 102	  +/-­‐	  18 90	  +/-­‐	  18
Day	  2 270	  +/-­‐	  42 240	  +/-­‐	  42
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Table	  S3.	  Secondary	  Screen
N
60
10
2
20%
#Lines	  Tested/Construct
1	  line 22
2	  lines 24
3	  lines 14
Total	  Stable	  Experiments 232
Constructs	  Tested	  1x 9
2x 13
>3x 38
Experiments	  Conducted
HS-­‐Constructs	  Made	  into	  Stable	  Lines
Stable	  Repeats	  Primary	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Supplemental Figure Legends 
Figure S1. Screen-wide frequency distributions of sleep/wake behavioral parameters 
(Related to Figure 1). (A-F) Histograms of behavioral indices from the primary screen, 
normalized as standard deviations from the mean (Z-score). Blue indicates the whole collection of 
experiments and red indicates the secondary selection of 60 Secretome genes that were chosen 
based on that parameter result. Most of the outliers with effects as strong as Nmu that were not 
chosen had failed to reproduce in repeated transient injection tests. See Figure 1, Table S2, and 
Supplemental Experimental Procedures for additional information about how the parameters and 
indices were calculated. 
 
Figure S2. Sequences of wild type and mutant Nmu, Nmur1 and Nmur2 (Related to Figure 
2). Nucleotide sequences of open reading frames of zebrafish wild type and mutant nmu (A, 
ENSDARG00000043299), nmur1a (C, ENSDARG00000060884), nmur1b (D, 
ENSDARG00000003944) and nmur2 (F, ENSDARG00000022570) are shown. Zebrafish 
orthologs were identified by reciprocal Blast searches of mammalian and zebrafish genomes. Red 
boxes indicate binding sites of ZFNs (C, D) and TALENs (A, F) used to generate mutants. 
Alignments of amino acid sequences of human, mouse, wild type zebrafish and mutant zebrafish 
Nmu (B; human, ENSG00000109255; mouse, ENSMUSG00000029236), Nmur1 (E; human, 
ENSG00000171596; mouse, ENSMUSG00000026237) and Nmur2 (G; human, 
ENSG00000132911; mouse, ENSMUSG00000037393) are shown. Amino acids shaded in black 
are identical to human. Blue lines indicate mature human Nmu peptide (B) and predicted human 
Nmur transmembrane domains (E, G). Asterisks in (B) indicate conserved residues that are critical 
for biological activity in mammals. H. Phylogenetic tree of human, mouse and zebrafish Nmu 
receptors. 
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Figure S3. Time course of Nmu overexpression (Related to Figure 3). Larvae from a 
hs:Nmu_Dr /+ to WT mating were heat shocked for 1 hour at 37oC at 5 dpf and fixed at the 
indicated times after heat shock. ISH was then performed using an nmu-specific riboprobe on 
dissected larval brains. Transgenic and WT larvae were subsequently identified by PCR. 
Ubiquitous nmu overexpression was observed at 1 hour post-heat shock, with reduced levels at 2 
and 4 hours post-heat shock. No ectopic transcript was observed at 16 and 24 hours post-heat 
shock. No ectopic nmu expression was observed in non-heat shocked transgenic brains (No HS, 
insert). Chromogenic development was stopped at the same time for all samples prior to the 
visualization of endogenous nmu transcript. While this data shows that ectopic nmu transcript 
levels are ubiquitously elevated for a few hours after heat shock, the perdurance of Nmu peptide is 
not known. 
 
Figure S4. Nmu overexpression phenotypes persist in the absence of circadian cues (Related 
to Figure 3). Nmu overexpression increases wake activity (A, A’) and decreases sleep (B, B’) in 
larvae entrained to LD and switched to constant light (LD-LL) conditions. Hatched boxes in the x-
axis indicate subjective night. Nmu overexpression increases wake activity (C, C’) and decreases 
sleep (D, D’) in larvae entrained to LD and switched to constant dark conditions (LD-DD). 
Hatched boxes in x-axis indicate subjective day. (E, F) Larvae raised in constant light from birth 
(LL-LL) do not exhibit a circadian wake activity or sleep rhythms, and Nmu-induced phenotypes 
persist in the absence of entrained or external circadian cues. Number of subjects: (A, B) 
hs:Nmu/+ (n=98), WT (n=92). (C, D) hs:Nmu/+ (n=90), WT (n=98). (E, F) hs:Nmu/+ (n=92), WT 
(n=98). ***p<0.001, Mann-Whitney U-test. 
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Figure S5. Larval nmu receptor mutants lack sleep/wake phenotypes and Nmu-induced 
hyperactivity and insomnia do not require nmur1a or nmur1b (Related to Figure 5). Larvae 
with homozygous and heterozygous mutations of nmur1a (A, B) or nmur1b (C, D) respond to 
Nmu overexpression, indicating that these receptors are not required for hs:Nmu-induced 
phenotypes. For hs:Nmu/+ neg. larvae, all comparisons between nmur1a-/-, nmur1a+/- and 
nmur1a+/+ siblings, and between nmur1b-/-, nmur1b+/- and nmur1b+/+ siblings, were not 
significantly different. nmur2-/- larvae exhibit slightly less wake activity at night compared to 
nmur2+/- and nmur2+/+ siblings (E), but there is no significant difference in wake activity during 
the day (E) or in sleep (F) among the three genotypes. Two month old nmur2-/- adults exhibit 
reduced activity compared to their nmur2+/- and nmur2+/+ siblings during the day (G, G’) and 
following night to day transitions (H, H’). Data in adult line graphs are averaged in 10 (G) or 1 (H) 
minute bins. Adult animals were derived from a nmur2+/- to nmur2+/- mating. Number of 
subjects for nmur1a mutant experiment: hs:Nmu/+; nmur1a-/- (n=22), hs:Nmu/+; nmur1a+/- 
(n=9), hs:Nmu/+; nmur1a+/+ (n=22), nmur1a-/- (n=23), nmur1a+/- (n=54), nmur1a+/+ (n=18). 
Number of subjects for nmur1b mutant experiment: hs:Nmu/+; nmur1b-/- (n=29), hs:Nmu/+; 
nmur1b+/- (n=43), hs:Nmu/+; nmur1b+/+ (n=25), nmur1b-/- (n=22), nmur1b+/- (n=39), 
nmur1b+/+ (n=17). Number of subjects for nmur2 mutant larval experiment: nmur2-/- (n=106), 
nmur2+/- (n=233), nmur2+/+ (n=108). Number of subjects for nmur2 mutant adult experiment: 
nmur2-/- (n=8), nmur2+/- (n=3), nmur2+/+ (n=5). *p<0.05, **p<0.01, ***p<0.001, n.s. p>0.05, 
Kruskal-Wallis test followed by the Steel-Dwass test for pairwise multiple comparisons. 
 
Figure S6. nmu-/- and nmur1a-/- but not nmur1b-/- or nmur2-/- adult zebrafish exhibit 
defects in size and weight (Related to Figure 5). (A) Representative images of male 20-22 week 
old adults from each genotype tested. For each mutation, fish from heterozygous mutant matings 
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were raised to adulthood, measured and then genotyped to identify homozygous mutant, 
heterozygous mutant and WT individuals. All samples are displayed at the same scale (scale bar = 
10 mm). (B) Size, as measured from rostral tip to end of torso (fin length not included), and 
weight of individual fish. Red=female, blue=male. Black horizontal bars indicate median value for 
each genotype. ***p<0.001, n.s. p>0.05, Kruskal-Wallis test followed by the Steel-Dwass test for 
pairwise multiple comparisons. 
 
Table S1. Primary screen summary data (Related to Figure 1). This table shows a summary of 
the experiments performed in the primary screen. Fewer unique genes were tested than unique 
ORFs because some genes contained splice variants that encode for more than one ORF. Duplicate 
ORFs and duplicate genes refer to the number of unique ORFs and unique genes that were tested 
more than once. Empty hs vector denotes negative control consisting of the Gateway destination 
vector that was not recombined to insert an ORF 3’ to the heat shock promoter. hs:Hcrt denotes 
positive control containing the zebrafish Hcrt ORF. hs:EGFP denotes negative control containing 
the EGFP ORF. Most experiments used the empty hs vector as a negative control. 
 
Table S2. Primary screen raw data (Related to Figure 1). This table shows mean±standard 
deviation values of all behavioral parameters quantified in the primary screen during day and night 
periods before and after heat shock. Data for overexpressed ORFs (Screen Data) and negative 
controls (Control Data) are shown. Most overexpressed ORFs did not induce phenotypes, so 
Screen Data and Control Data values are similar. 
 
Table S3. Secondary screen summary data (Related to Figure 1). This table shows summary 
statistics for the 60 human ORFs for which stable transgenic lines were generated. Of the 60 
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ORFs, 10 produced overexpression phenotypes similar to those observed in the primary screen. 
Two ORFs produced overexpression phenotypes different from those observed in the primary 
screen. Two or three independent stable transgenic lines were generated for 24 or 14 of the ORFs, 
respectively. Most stable transgenic lines were tested for overexpression phenotypes in 3 or more 
independent behavioral experiments. 
 
Movie S1. nmu expression in a 5 dpf larval zebrafish brain (Related to Figure 2). At 5 dpf, 
nmu is expressed in several ventral hypothalamic cell clusters, a dorsal hypothalamic bilateral 
cluster, and a few cells in the lateral-caudal brainstem. The movie progresses from ventral to 
dorsal focal planes imaged at 5 µm intervals. The large dark spots in the most dorsal images are 
pigment cells. 
 
Movie S2. nmur2 expression in a 5 dpf larval zebrafish brain (Related to Figure 2). At 5 dpf, 
nmur2 is broadly expressed in discrete regions of the brain, including cell clusters in the 
brainstem, hypothalamus and forebrain. The movie progresses from ventral to dorsal focal planes 
imaged at 5 µm intervals. The large dark spots in the most dorsal images are pigment cells. 
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Supplemental Experimental Procedures 
Animal use 
Zebrafish were raised on a 14 hour:10 hour light:dark cycle at 28.5◦C, with lights on at 9 a.m. and 
off at 11 p.m. WT, transgenic, and mutant stocks come from a background of TL x AB WT 
strains. All experiments with zebrafish followed standard protocols (Westerfield, 2000) in 
accordance with the Harvard University and California Institute of Technology Institutional 
Animal Care and Use Committee guidelines. 
 
Generation of Secretome library and microinjection assay 
The LOCATE database (http://locate.imb.uq.edu.au) identifies 4418 human proteins that are 
predicted or known to be secreted. ORFs that encode 1632 of these proteins were present in the 
hORFeome 3.1 collection in Gateway entry vectors (Lamesch et al., 2007). We constructed a 
Gateway destination vector containing a heat shock-inducible promoter (Halloran et al., 2000) 5’ 
to attR1 and an SV40 polyadenylation signal 3’ to attR2, and the entire cassette was flanked by 
Tol2 transposase arms. LR clonase (Invitrogen) was used to transfer each ORF into the destination 
vector. Plasmid preps were obtained using a Qiagen Biorobot 8000, purified using multiscreen 
PCR µ96 filter plates (LSKMPCR10, Millipore), dried using a speedvac, and dissolved in 10 µL 
water. Plasmid concentrations were measured using the Quant-iT kit (Invitrogen) and adjusted to 
100 ng/µL. The purification step allowed injection of twice as much DNA compared to non-
purified samples without increased toxicity. One nL of an injection mix (50 ng/µL plasmid, 150 
ng/µL tol2 transposase mRNA and 0.05% phenol red in PBS (P0290, Sigma-Aldrich)) was 
injected into the yolk of TLAB embryos at the one-cell stage. Each plasmid was injected into 50 
embryos, and up to 32 larvae were tested in the behavioral assay. Injected animals were screened 
at 24 hpf and immediately prior to the behavioral assay to remove any larvae that exhibited 
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abnormal morphology or locomotor behaviors. Plasmids for which fewer than 24 healthy larvae 
were available to test were reinjected at 25 ng/µL. For behavioral testing, individual larvae were 
placed into each of 80 wells of a 96-well plate (7701-1651, Whatman) containing 650 µL embryo 
water (0.3 g/L Instant Ocean, 1 mg/L methylene blue, pH 7.0). Two plasmids were tested in each 
plate on 32 animals per plasmid. At 4 dpf, larvae injected with each plasmid were loaded in 
alternating columns, and control larvae injected with the destination vector lacking an ORF or 
containing EGFP were loaded in columns 1 and 10. 
 
After the primary screen, post-HS day and night sleep, wake activity, and sleep bout number, 
length and latency were calculated for each clone tested as described (Rihel et al., 2010): sleep is 
defined as one minute of inactivity; sleep bouts are the number of uninterrupted runs of sleep; 
sleep length is the average time a sleep bout lasts; sleep latency is the time from lights out to first 
sleep bout; and wake activity is the amount of locomotor activity during active bouts. The activity 
index was determined as: 
 Activity Index     =   (PostNightn - PreNightn) + 0.5(PostD1n +PostD2n)- PreDayn) 
                   1/N ∑(PostNightc - PreNightc + 0.5(PostD1c +PostD2c) - PreDayc) 
 
Z-scores were determined by subtracting the mean of all tested clones from the measure of each 
clone, divided by the standard deviation of all tested clones. 
 
Secondary screening in stable transgenic lines 
Sixty clones that produced the same phenotype upon retesting in the injection overexpression 
assay were used to generate stable transgenic lines using Tol2 transposase or ISce1 meganuclease. 
Stable lines were identified by heat shocking the progeny of potential founders at 24 hpf, fixing 
the embryos with 4% paraformaldehyde (PFA) in phosphate buffered saline (PBS) 1 hour after 
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heat shock, and performing ISH using a probe specific for the overexpressed ORF. Lines that 
produced strong and ubiquitous gene overexpression were used for behavioral assays. When 
available, up to three independent stable lines were behaviorally tested for each ORF (Table S3) in 
the locomotor activity assay. 
 
Locomotor activity assay 
At 4 dpf, individual larvae were placed into each 650 µL well of a 96-well plate (7701-1651, 
Whatman). For the primary screen, only 80 wells of the plate were used due to software and 
hardware limitations. For subsequent experiments, all 96 wells were used. In experiments using 
stable transgenic or mutant lines, larvae were blindly assigned a position in the plate, and were 
genotyped after the behavioral experiment was completed. Except in the primary screen or as 
noted, plates were filled E3 embryo medium and sealed with an optical adhesive film (4311971, 
Applied Biosystems) to prevent evaporation. Occasionally, the sealing process introduces air 
bubbles in some wells, which occlude tracking of larvae and are discarded from analysis. 
Locomotor activity was monitored using an automated videotracking system (Viewpoint Life 
Sciences) with a one-third inch monochrome camera (primary screen: LTC0385, Bosch; 
subsequent experiments: Dragonfly 2, Point Grey) fitted with a fixed-angle megapixel lens 
(M5018-MP, Computar) and infrared filter. Larvae were heat shocked at 37◦C for one hour 
starting around 4 p.m. or 5 p.m. on 5 or 6 dpf. The movement of each larva was captured at 15 Hz 
and recorded using the quantization mode with 1-minute integration time bins. In the primary 
screen, data from two cameras were collected in alternating minutes by one computer; in 
subsequent experiments, one computer collected data from two cameras simultaneously. The 96-
well plate and camera were housed inside a custom-modified, opaque Zebrabox (Viewpoint Life 
Sciences) that was continuously illuminated with infrared LEDs, and illuminated with white LEDs 
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from 9 a.m. to 11 p.m., except as noted in constant light or constant dark experiments. The 96-well 
plate was housed in a chamber filled with recirculating water to maintain a constant temperature of 
28.5◦C. The parameters used for detection with the Bosch (primary screen) / Point Grey 
(subsequent experiments) cameras were the following: detection threshold, 40/14; burst, 25/29; 
freeze, 3/4. Data were processed using custom PERL and Matlab (The Mathworks, Inc) scripts. 
 
For adult behavioral assays, individual two month (nmur2 mutant) or three month (nmu mutant) 
old zebrafish were randomly placed into a 7 cm x 12 cm by X 8.5 cm (WxLxH) open topped, 
transparent plastic chamber, with three small holes (5 mm, partially covered with parafilm for 
smaller adults) to allow water exchange. The chambers (8 per tracking session) were placed into a 
semi-transparent, plastic 46 cm x 54 cm chamber, which was supplied with aquarium fish water 
(water height in chamber: 4.5 cm), pumped from a 45 L reservoir with an aquarium pump (Maxi-
Jet, MJ500) at a flow rate of 1.3 L/min and heated to 28oC with an aquarium heater (HT100; 
Tetra). The chamber was continuously illuminated from below with two panels of infrared lights 
(60 Degree, 54 LED Video Camera Red Infrared Illuminator Lamp, SourcingMap) with the 
detector covered, and illuminated from above with white light (180 lux at water surface) from 9 
a.m. to 11 p.m. The chambers were monitored with a ceiling mounted (143 cm from chamber to 
lens) Dinion one-third inch Monochrome camera (LTC0385; Bosch) fitted with a 13-36 mm, 
1:2:8, 2/3’’ lens (Computar). The entire setup was housed in an isolated darkroom. Fish were 
continuously tracked for two to four days at 15 Hz using an automated videotracking system 
(Viewpoint Life Sciences) in tracking mode, with a background threshold of 40, inactive/small 
movement cutoff of 1.3 cm/sec, and small/large movement cutoff of 8 cm/sec. Each track was 
visually inspected at 1 minute resolution for any artifactual movements (e.g. from stray particles 
or air bubbles) and then analyzed using custom Matlab scripts (The Mathworks, Inc). Fish were 
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derived from a nmu-/- to nmu+/- mating and a nmur2+/- to nmur2+/- mating. Mixed gender 
siblings were raised in groups of 30-40 per tank and were genotyped by fin clip after the 
behavioral assay. 
 
Light pulse-evoked arousal assay 
Larval zebrafish were housed and monitored as described for the locomotor assay, except activity 
was stored in 1-second integration time bins and data were subsequently smoothed with a 10-
second running average. One-minute light pulse trials were presented at 2 hour intervals starting 2 
hours after the start of the dark phase (i.e. 1 a.m.). The full dataset consisted of 870 trials each for 
hs:Nmu/+ and WT sibling genotypes, which were randomly subdivided to generate n=29 samples 
per genotype, with each sample representing a 30-trial average. The baseline for each sample was 
measured as the median activity level during the 30 minutes prior to stimulus onset. The peak 
amplitude (A1) during first “stimulus-on” response epoch was defined as the peak raw activity 
level during the stimulus period minus the sample baseline. The peak amplitude (A2) of the “post-
stimulus” response epoch was determined in two steps. First, an alpha function was fit to the 
“post-stimulus” response, as given in Equation 1: 
Eq. 1: y(t) =  baseline + t * e -(t/ τ) 
with time t, and free decay parameter τdecay.  Second, the A2 was calculated as peak value of the 
alpha curve fit minus baseline. Next, the exponential decay function that was fit to the “stimulus-
on” or “post-stimulus” epochs of the response curve is given in Equation 2: 
Eq. 2: y(t) =  baseline + A* e -(t/ τ) 
with time t, peak amplitude A1 or A2, and free decay parameter τ1 or τ2, for the “stimulus-on” and 
post-stimulus response periods, respectively. Total activity for “stimulus-on” was calculated as the 
integral of raw activity (∫ Activity1) data during the 6 minutes after stimulus onset. Total activity 
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for “post-stimulus” response was calculated as the integral of raw activity (∫ Activity2) during 
subsequent time points through τ2. 
 
Generation of zebrafish heat-shock inducible transgenic lines 
We used reciprocal BLAST to identify zebrafish orthologs for each human ORF that produced a 
locomotor activity phenotype in stable transgenic lines. To clone the zebrafish ORFs, we 
performed RT-PCR (Superscript III Reverse Transcriptase, Life Technologies) using mRNA 
isolated from 5 dpf zebrafish larvae (Trizol, Life Technologies). In cases where the 5’ or 3’ end of 
an ORF was not annotated in Ensembl or was ambiguous, 5’ and 3’ RACE (First Choice RLM-
RACE Kit, Life Technologies) was performed to identify the entire ORF. Each ORF was cloned 
into a vector containing a heat-shock inducible promoter (Halloran et al., 2000) and ISce1 
meganuclease sites, and each vector was injected with ISce1 (New England Biolabs) into zebrafish 
embryos at the one-cell stage to generate stable lines, which were identified as described above. 
 
Generation of zebrafish mutants 
nmu and nmur2 mutant zebrafish were generated using TAL effector nucleases (TALENs), as 
described (Chen et al., 2013; Reyon et al., 2012). nmur1a and nmur1b mutant zebrafish were 
generated using zinc finger nucleases (ZFNs), as described (Chen et al., 2013). Plasmids were 
obtained from Addgene. nmu mutants were genotyped using the primers 5’-
TGACCGACAGAGAGCATGAG-3’, 5’-GGAGTAGTACCGCGAGCATC-3’ and 5’-
CGATTAAAACAGTAAAAACGCAGA-3’, which generate 172 bp and 106 bp bands for the WT 
allele and a 168 bp band for the mutant allele. nmur1a mutants were genotyped using the primers 
5’-AGACACCCTGTATTTTCTCCTCA-3’, 5’-GTAGAGGACGGGGTTTATGG-3’ and 5’-
CACATCGGAGCTAGCGAAAC-3’, which generate a 203 bp band for the WT allele, and 214 bp 
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and 96 bp bands for the mutant allele. nmur1b mutants were genotyped using the primers 5’-
TCAATGATACAGTACAACTGCTCCTC-3’, 5’-AGGGTCCAAGGTATTTCTCCA-3’ and 5’-
ATGGTGCTCCACCAAAGAA-3’, which generate 163 bp and 101 bp bands for the WT allele 
and a 158 bp band for the mutant allele. nmur2 mutants were genotyped using the primers 5’-
ATGACCGGGGTCTTAGGAAA-3’ and 5’-TGACGTTTAACACGGAAGCA-3’, which 
generate a 244 bp band for the WT allele and a 227 bp band for the mutant allele. The grs357 
mutant (Ziv et al., 2013) and was a kind gift from Herwig Baier. These animals were genotyped 
using the primers 5’-GGAAGAACTGaCCTGCCTGT-3’ and 5’-
TCTCAGTTTATCCACATTTATGCAG-3’. DrdI digests the WT PCR product into 114 and 14 
bp bands. 
 
in situ hybridization and imaging 
Samples were fixed in 4% PFA in PBS for 12-16 hours at room temperature. in situ hybridizations 
(ISH) were performed using digoxygenin (DIG) labeled antisense riboprobes (DIG RNA Labeling 
Kit, Roche) or  2,4-dinitrophenol (DNP) labeled antisense riboprobes (DNP-11-UTP, Perkin 
Elmer) as previously described (Thisse and Thisse, 2008). Double-fluorescent ISH was performed 
using DIG- and DNP- labeled riboprobes and the TSA Plus Fluorescein and Cyanine 3 Systems 
(Perkin Elmer). PCR products generated from larval zebrafish cDNA were used as templates for 
riboprobe synthesis using the following primers. nmu: 5’-CATGAGGAACAGCAATCAATG-3’ 
and 5’-TAATACGACTCACTATAGGGACACATACTCATCAGATCTTCTTCC-3’ (524 bp). 
nmur1a: 5’-GGCATTAAACCTCACCGAGA-3’ and 5’-
TAATACGACTCACTATAGGGCACGTTTCGTCAAGAAATCAAA-3’ (1620 bp). nmur1b: 5’-
GTGAACACGTCATGGTGCTC-3’ and 5’-
TAATACGACTCACTATAGGGGCGTTGGTATTCAGAAACTGC-3’ (1206 bp). nmur2: 5’-
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CTCCTGACCTGCGCTGTAAT-3’ and 5’-
TAATACGACTCACTATAGGGGAGGAGCTGAACTTGACTTGC-3’ (1486 bp). Plasmids 
containing crh (genbank clone CK352624, 849 bp) and cfos (genbank clone CA787334, 870 bp) 
expressed sequence tags were also used for riboprobe synthesis.  
 
Samples were coverslip mounted in 80% glycerol in PBS and imaged using a compound 
microscope (Axioimager with EC Plan-Neofluar 10x/0.30 NA Air or Plan-Apochromat 20x/0.8 
NA Air objective, Carl Zeiss MicroImaging, Inc.) for chromogenic ISH samples, or for double 
fluorescent ISH samples, a confocal microscope (LSM 780 with a Plan-Apochromat 10x/0.45 NA 
Air or LD C-Apochromat 40x/1.1 NA Water objective, Carl Zeiss MicroImaging, Inc.). 
Fluorescein and Cyanine were imaged in separate channels with a 488 nm or 561 nm laser, 
respectively. Confocal images are displayed as the maximum intensity z-projection of a stack of 
optical sections of approximately 1 airy unit (A.U.) thickness and 0.5 A.U. spacing. 
 
Drug treatment 
A 20 mM stock of 5-Chloro-N-(cyclopropylmethyl)-2-methyl-N-propyl-N'-(2,4,6-
trichlorophenyl)-4,6-pyrimidinediamine hydrochloride (NBI 27914, Cat#1591, Tocris) was freshly 
prepared in dimethyl sulfoxide (DMSO) just prior to drug treatment. Immediately after the 37°C 
heat shock treatment from noon to 1 p.m. on 5 dpf, drug and vehicle were loaded into alternating 
columns of an open (i.e. not sealed) 96-well plate to make a final working concentration of 5 µM 
NBI 27914 in 0.05% DMSO, or 0.05% DMSO (vehicle only) in E3 embryo medium. Separate 
experiments were performed with the same procedure as above at 2 µM or 0.5 µM NBI 27914 in 
0.05% DMSO and included within-experiment, vehicle only controls. For the dose-response 
graph, post-HS Day waking activity data across separate experiments (i.e. different drug 
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concentrations and controls) were normalized to within-experiment, vehicle-only controls before 
being pooled for analysis. 
 
Weight and size measurements of adult zebrafish 
Samples were generated from heterozygous x heterozygous mutant crosses for each mutation. To 
match environmental conditions across genotypes, sibling fish were raised in genotype-intermixed 
tanks (6 per 1.8 L tank) at 28.5°C until measurement at 20-22 weeks post fertilization. Thus, 
phenotypes for each mutation were compared across age- and housing-matched siblings. Fish were 
briefly anesthetized with tricaine, photographed, then blotted and weighed. Torso length was 
measured as the linear distance between the rostral tip to the end of the trunk, not including the tail 
fin. Each fish was then genotyped by fin clip and PCR as described above. Up to 6 each of males 
and females were measured for each genotype.  
	   26	  
Supplemental References 
Chen, S., Oikonomou, G., Chiu, C.N., Niles, B.J., Liu, J., Lee, D.A., Antoshechkin, I., and Prober, 
D.A. (2013). A large-scale in vivo analysis reveals that TALENs are significantly more mutagenic 
than ZFNs generated using context-dependent assembly. Nucleic Acids Res 41, 2769-2778. 
Halloran, M.C., Sato-Maeda, M., Warren, J.T., Su, F., Lele, Z., Krone, P.H., Kuwada, J.Y., and 
Shoji, W. (2000). Laser-induced gene expression in specific cells of transgenic zebrafish. 
Development 127, 1953-1960. 
Lamesch, P., Li, N., Milstein, S., Fan, C., Hao, T., Szabo, G., Hu, Z., Venkatesan, K., Bethel, G., 
Martin, P., et al. (2007). hORFeome v3.1: a resource of human open reading frames representing 
over 10,000 human genes. Genomics 89, 307-315. 
Reyon, D., Khayter, C., Regan, M.R., Joung, J.K., and Sander, J.D. (2012). Engineering designer 
transcription activator-like effector nucleases (TALENs) by REAL or REAL-Fast assembly. Curr 
Protoc Mol Biol Chapter 12, Unit 12 15. 
Rihel, J., Prober, D.A., Arvanites, A., Lam, K., Zimmerman, S., Jang, S., Haggarty, S.J., Kokel, 
D., Rubin, L.L., Peterson, R.T., et al. (2010). Zebrafish behavioral profiling links drugs to 
biological targets and rest/wake regulation. Science 327, 348-351. 
Thisse, C., and Thisse, B. (2008). High-resolution in situ hybridization to whole-mount zebrafish 
embryos. Nat Protoc 3, 59-69. 
Westerfield, M. (2000). The zebrafish book. A guide for the laboratory use of zebrafish (Danio 
rerio). 4th Edition. (Univ. of Oregon Press, Eugene). 
Ziv, L., Muto, A., Schoonheim, P.J., Meijsing, S.H., Strasser, D., Ingraham, H.A., Schaaf, M.J., 
Yamamoto, K.R., and Baier, H. (2013). An affective disorder in zebrafish with mutation of the 
glucocorticoid receptor. Molecular psychiatry 18, 681-691. 
 
  
Movie S1
Click here to access/download
Supplemental Movies & Spreadsheets
Chiu et al Movie S1.mp4
  
Movie S2
Click here to access/download
Supplemental Movies & Spreadsheets
Chiu et al Movie S2.mp4
